Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Mar. 10, 2023 | Jun. 30, 2022 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Current Fiscal Year End Date | --12-31 | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Transition Report | false | ||
Entity File Number | 001-40950 | ||
Entity Registrant Name | The Vita Coco Company, Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 11-3713156 | ||
Entity Address, Address Line One | 250 Park Avenue South | ||
Entity Address, Address Line Two | Seventh Floor | ||
Entity Address, City or Town | New York | ||
Entity Address, State or Province | NY | ||
Entity Address, Postal Zip Code | 10003 | ||
City Area Code | 212 | ||
Local Phone Number | 206-0763 | ||
Title of 12(b) Security | Common Stock, Par Value $0.01 Per Share | ||
Trading Symbol | COCO | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
ICFR Auditor Attestation Flag | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 271.1 | ||
Entity Common Stock, Shares Outstanding | 56,047,737 | ||
Documents Incorporated by Reference | Portions of the registrant’s definitive Proxy Statement relating to its 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2022 are incorporated herein by reference in Part III. | ||
Entity Central Index Key | 0001482981 | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2022 | |
Audit Information [Abstract] | |
Auditor Firm ID | 34 |
Auditor Name | Deloitte & Touche LLP |
Auditor Location | New York, New York |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 19,629 | $ 28,690 |
Accounts receivable, net of allowance of $2,898 at December 31, 2022, and $1,301 at December 31, 2021 | 43,350 | 47,195 |
Inventory | 84,115 | 75,360 |
Supplier advances | 1,534 | 1,170 |
Derivative assets | 3,606 | 126 |
Asset held for sale | 503 | 0 |
Prepaid expenses and other current assets | 22,181 | 20,718 |
Total current assets | 174,918 | 173,259 |
Property and equipment, net | 2,076 | 2,473 |
Goodwill | 7,791 | 7,791 |
Intangible assets, net | 0 | 7,934 |
Supplier advances | 4,360 | 2,808 |
Deferred tax assets, net | 4,256 | 1,265 |
Right-of-use asset | 2,679 | 0 |
Other assets | 1,677 | 1,954 |
Total assets | 197,757 | 197,484 |
Current liabilities: | ||
Accounts payable | 15,910 | 28,338 |
Accrued expenses | 38,342 | 42,399 |
Notes payable, current | 23 | 28 |
Derivative liabilities | 71 | 3,197 |
Total current liabilities | 54,346 | 73,962 |
Credit facility | 0 | 0 |
Notes payable | 25 | 48 |
Other long-term liabilities | 2,293 | 301 |
Total liabilities | 56,664 | 74,311 |
Stockholders' equity: | ||
Common stock, $0.01 par value; 500,000,000 shares authorized; and 62,225,250 shares and 61,764,582 shares issued at December 31, 2022 and 2021, respectively; 56,019,050 and 55,558,382 shares outstanding at December 31, 2022 and 2021, respectively. | 622 | 618 |
Additional paid-in capital | 145,210 | 134,730 |
Retained earnings | 55,183 | 47,369 |
Accumulated other comprehensive loss | (994) | (616) |
Treasury stock, 6,206,200 shares at cost as of December 31, 2022, and December 31, 2021 | (58,928) | (58,928) |
Total stockholders' equity attributable to The Vita Coco Company, Inc. | 141,093 | 123,173 |
Noncontrolling interests | 0 | 0 |
Total stockholders' equity | 141,093 | 123,173 |
Total liabilities and stockholders' equity | $ 197,757 | $ 197,484 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance | $ 2,898 | $ 1,301 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (in shares) | 62,225,250 | 61,764,582 |
Common stock, shares outstanding (in shares) | 56,019,050 | 55,558,382 |
Treasury stock (in shares) | 6,206,200 | 6,206,200 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Net sales | $ 427,787 | $ 379,513 | $ 310,644 |
Cost of goods sold | 324,426 | 266,365 | 205,786 |
Gross profit | 103,361 | 113,148 | 104,858 |
Operating expenses | |||
Selling, general and administrative | 100,306 | 88,559 | 74,401 |
Change in fair value of contingent consideration | 0 | 0 | (16,400) |
Total operating expenses | 100,306 | 88,559 | 58,001 |
Income from operations | 3,055 | 24,589 | 46,857 |
Other income (expense) | |||
Unrealized gain (loss) on derivative instruments | 6,606 | 2,093 | (4,718) |
Foreign currency gain (loss) | 1,387 | (2,088) | 1,848 |
Loss on extinguishment of debt | 0 | (132) | 0 |
Interest income | 51 | 127 | 404 |
Interest expense | (258) | (360) | (791) |
Total other income (expense) | 7,786 | (360) | (3,257) |
Income before income taxes | 10,841 | 24,229 | 43,600 |
Income tax expense | (3,027) | (5,237) | (10,913) |
Net income | 7,814 | 18,992 | 32,687 |
Net income (loss) attributable to noncontrolling interest | 0 | (23) | 27 |
Net income attributable to The Vita Coco Company, Inc. | $ 7,814 | $ 19,015 | $ 32,660 |
Net income attributable to The Vita Coco Company, Inc. per common share | |||
Basic (in dollars per share) | $ 0.14 | $ 0.35 | $ 0.56 |
Diluted (in dollars per share) | $ 0.14 | $ 0.35 | $ 0.56 |
Weighted-average number of common shares outstanding | |||
Basic (in shares) | 55,732,619 | 53,689,910 | 58,501,170 |
Diluted (in shares) | 56,123,661 | 54,186,121 | 58,610,825 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | |||
Net income | $ 7,814 | $ 18,992 | $ 32,687 |
Other comprehensive income: | |||
Foreign currency translation adjustment | (378) | 320 | 346 |
Total comprehensive income including noncontrolling interest | 7,436 | 19,312 | 33,033 |
Net income (loss) attributable to noncontrolling interest | 0 | (23) | 27 |
Foreign currency translation adjustment attributable to noncontrolling interest | 0 | 4 | 5 |
Total comprehensive income (loss) attributable to noncontrolling interest | 0 | (19) | 32 |
Total comprehensive income attributable to The Vita Coco Company, Inc. | $ 7,436 | $ 19,331 | $ 33,001 |
Consolidated Statements of Non-
Consolidated Statements of Non-Controlling Interests and Stockholders' Equity - USD ($) $ in Thousands | Total | Total Stockholders' Equity Attributable to The Vita Coco Company, Inc. | Common Stock | Additional Paid-In Capital | Loan to Shareholder | Retained Earnings (Accumulated Deficit) | Accumulated Other Comprehensive Income / (Loss) | Treasury Stock | Non- controlling Interest in Subsidiary | Common Stock Common Stock | Common Stock with Exit Warrants Common Stock |
Beginning balance (in shares) at Dec. 31, 2019 | 58,906,575 | 211,575 | 50,793,470 | 8,113,105 | |||||||
Beginning balance at Dec. 31, 2019 | $ 73,799 | $ 73,753 | $ 589 | $ 98,450 | $ (17,700) | $ (4,306) | $ (1,295) | $ (1,985) | $ 46 | $ 508 | $ 81 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
Net income | 32,687 | 32,660 | 32,660 | 27 | |||||||
Purchase of treasury stock (in shares) | 802,620 | ||||||||||
Purchase of treasury stock | (6,940) | (6,940) | $ (6,940) | ||||||||
Stock-based compensation | 1,517 | 1,517 | 1,517 | ||||||||
Exercise of stock options (in shares) | 177,450 | 177,450 | |||||||||
Exercise of stock options | 884 | 884 | $ 2 | 882 | $ 2 | ||||||
Exercise of service warrants (in shares) | 116,025 | 116,025 | |||||||||
Exercise of service warrants | 1 | 1 | $ 1 | $ 1 | |||||||
Foreign currency translation adjustment | 351 | 346 | 346 | 5 | |||||||
Ending balance (in shares) at Dec. 31, 2020 | 59,200,050 | 1,014,195 | 51,086,945 | 8,113,105 | |||||||
Ending balance at Dec. 31, 2020 | 102,299 | 102,221 | $ 592 | 100,849 | (17,700) | 28,354 | (949) | $ (8,925) | 78 | $ 511 | $ 81 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
Net income | 18,992 | 19,015 | 19,015 | (23) | |||||||
Purchase of treasury stock (in shares) | 5,192,005 | ||||||||||
Purchase of treasury stock | (50,003) | (50,003) | $ (50,003) | ||||||||
Issuance of common shares (in shares) | 2,500,000 | 2,500,000 | |||||||||
Issuance of common stock pursuant to initial public offering, net of underwriting discounts and offering costs | 30,356 | 30,356 | $ 25 | 30,331 | $ 25 | ||||||
Loan to stockholder | 17,700 | 17,700 | 17,700 | ||||||||
Stock-based compensation | 3,380 | 3,380 | 3,380 | ||||||||
Exercise of stock options (in shares) | 20,930 | 20,930 | |||||||||
Exercise of stock options | 178 | 178 | 178 | ||||||||
Acquisition of non-controlling interest (in shares) | 43,602 | 43,602 | |||||||||
Acquisition of non-controlling interest | (53) | 6 | $ 1 | (8) | 13 | (59) | $ 1 | ||||
Foreign currency translation adjustment | 324 | 320 | 320 | 4 | |||||||
Ending balance (in shares) at Dec. 31, 2021 | 61,764,582 | 6,206,200 | 53,651,477 | 8,113,105 | |||||||
Ending balance at Dec. 31, 2021 | 123,173 | 123,173 | $ 618 | 134,730 | 0 | 47,369 | (616) | $ (58,928) | 0 | $ 537 | $ 81 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
Net income | 7,814 | 7,814 | 7,814 | 0 | |||||||
Stock-based compensation | 7,384 | 7,384 | 7,384 | ||||||||
Exercise of stock options (in shares) | 460,668 | 460,668 | |||||||||
Exercise of stock options | 3,100 | 3,100 | $ 4 | 3,096 | $ 4 | ||||||
Foreign currency translation adjustment | (378) | (378) | (378) | ||||||||
Ending balance (in shares) at Dec. 31, 2022 | 62,225,250 | 6,206,200 | 54,112,145 | 8,113,105 | |||||||
Ending balance at Dec. 31, 2022 | $ 141,093 | $ 141,093 | $ 622 | $ 145,210 | $ 0 | $ 55,183 | $ (994) | $ (58,928) | $ 0 | $ 541 | $ 81 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Cash flows from operating activities: | |||
Net income | $ 7,814 | $ 18,992 | $ 32,687 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 1,901 | 2,069 | 2,125 |
(Gain)/loss on disposal of equipment | 1 | 112 | (5) |
Bad debt expense | 2,641 | 76 | 859 |
Unrealized (gain)/loss on derivative instruments | (6,606) | (2,093) | 4,718 |
Stock-based compensation | 7,384 | 3,380 | 1,517 |
Impairment loss on assets held for sale | 619 | 0 | 90 |
Impairment of intangible assets | 6,714 | 0 | 0 |
Deferred tax expense/(benefit) | (3,081) | (1,644) | 6,282 |
Noncash lease expense | 1,058 | 0 | 0 |
Change in fair value of contingent consideration | 0 | 0 | (16,400) |
Loss on extinguishment of debt | 0 | 132 | 0 |
Changes in operating assets and liabilities: | |||
Accounts receivable | 321 | (16,917) | 190 |
Inventory | (9,333) | (43,501) | 4,978 |
Prepaid expenses, net supplier advances, and other assets | (3,592) | 2,725 | (16,426) |
Accounts payable, accrued expenses, and other long-term liabilities | (16,776) | 20,503 | 12,708 |
Net cash provided by (used in) operating activities | (10,935) | (16,166) | 33,323 |
Cash paid for property and equipment | |||
Cash paid for property and equipment | (982) | (557) | (392) |
Proceeds from sale of property and equipment | 0 | 0 | 17 |
Net cash used in investing activities | (982) | (557) | (375) |
Cash flows from financing activities: | |||
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and offering costs | 0 | 30,356 | 0 |
Proceeds from exercise of stock options/warrants | 3,062 | 177 | 885 |
Proceeds from settlement of loan to stockholder | 0 | 17,700 | 0 |
Borrowings on credit facility | 22,000 | 0 | 25,000 |
Repayments of borrowings on credit facility | (22,000) | (25,000) | 0 |
Proceeds from the term loan | 0 | 30,000 | 0 |
Repayments of the term loan | 0 | (30,000) | 0 |
Cash received (paid) on notes payable | (28) | 21 | (16,895) |
Cash paid to acquire treasury stock | 0 | (50,003) | (6,940) |
Cash paid to acquire portion of non-controlling interest | 0 | (54) | 0 |
Net cash (used in) provided by financing activities | 3,034 | (26,803) | 2,050 |
Effects of exchange rate changes on cash and cash equivalents | (178) | 35 | 443 |
Net (decrease) increase in cash and cash equivalents | (9,061) | (43,491) | 35,441 |
Cash and cash equivalents at beginning of the period | 28,690 | 72,181 | 36,740 |
Cash and cash equivalents at end of the period | 19,629 | 28,690 | 72,181 |
Supplemental disclosures of cash flow information: | |||
Cash paid for income taxes | 4,624 | 2,440 | 9,718 |
Cash paid for interest | $ 217 | $ 349 | $ 812 |
Nature of Business and Basis of
Nature of Business and Basis of Presentation | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature of Business and Basis of Presentation | NATURE OF BUSINESS AND BASIS OF PRESENTATION The Vita Coco Company, Inc. and subsidiaries (the “Company”) develops, markets, and distributes various coconut water products under the brand name Vita Coco and for retailers own brands, predominantly in the United States. Other products include coconut milk, natural energy drinks (under the brand name Runa ), coconut oil, water (under the brand name Ever & Ever ), protein infused fitness drinks (under the brand name PWR LIFT) and coconut as a commodity. The Company was incorporated in Delaware as All Market Inc. on January 17 th , 2007. On September 9, 2021, we changed our name to The Vita Coco Company, Inc. In 2018, the Company purchased certain assets and liabilities of Runa , which is marketed and distributed primarily in the United States. We are a public benefit corporation under Section 362 of the Delaware General Corporation Law. As a public benefit corporation, our board of directors is required by the Delaware General Corporation Law to manage or direct our business and affairs in a manner that balances the pecuniary interests of our stockholders, the best interests of those materially affected by our conduct, and the specific public benefits identified in our certificate of incorporation. The Company has nine wholly-owned subsidiaries including four wholly-owned Asian subsidiaries established between fiscal years 2012 and 2015, one North American subsidiary established in 2015, as well as majority ownership in All Market Europe, Ltd. ("AME") in the United Kingdom until the Company reacquired the minority stockholders' shares and became wholly-owned as of December 31, 2021. The noncontrolling interest in AME represented minority stockholders’ proportionate share of the equity in AME. The noncontrolling interest is presented in the equity section of the Company’s consolidated balance sheets. Basis of Presentation The accompanying consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Principles of Consolidation The consolidated financial statements include all the accounts of the wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation; the noncontrolling interest in consolidated subsidiaries presented in the accompanying consolidated financial statements represents the portion of AME stockholders’ equity, which is not directly owned by the Company. Initial Public Offering (“IPO”) The Company’s registration statement on Form S-1, as amended, was declared effective by the SEC on October 20, 2021 related to the IPO of its common stock in the prospectus dated October 20, 2021, filed with the SEC in accordance with Rule 424(b)(4) of the Securities Act on October 22, 2021 (the “Prospectus”). On October 21, 2021, the Company’s shares began trading on the NASDAQ under the ticker symbol “COCO”. On October 25, 2021, we completed our IPO by issuing 2,500,000 shares of our common stock, $0.01 par value per share, at a price to the public of $15 per share, resulting in net proceeds to us of approximately $30,000, after deducting the underwriting discount and commissions of approximately $2,000 and offering expenses of approximately $5,000. Additionally, certain selling stockholders sold an aggregate of 9,000,000 shares. The Company did not receive any proceeds from the sale of these shares by certain selling stockholders. On October 27, 2021, the Company used the net proceeds from the IPO to repay the outstanding balance on the 2021 Term Loan. See Note 10 for additional information on the repayment of the 2021 Term Loan. Concurrent with the IPO, various agreements were amended or newly effective, which are further described in our Prospectus, which include: • The Registration Rights agreement; • The Investor Rights agreement; • Amendments to the employment agreements for the Executive Chairman, Mike Kirban and CEO, Martin Roper; • Adoption of the new 2021 Stock Incentive Award Plan and new grants of awards to employees and directors; and • Adoption of a new 2021 Employee Stock Purchase Plan. Impact of the COVID-19 Pandemic and Current Geopolitical Instability Disruptions in the worldwide economy may affect our business, and the macroeconomic environment continues to be affected by the COVID-19 pandemic and the current geopolitical instability (including the effects of the conflict between Ukraine and Russia). As a result, the Company has seen significant cost inflation to domestic and international shipping costs and some inflationary pressures on other cost elements; only some of which have been covered by pricing actions to date. The Company is continuing to monitor the situation carefully to understand any future potential impact on its people and business. As a result, it is not currently possible to ascertain the overall impact of COVID-19 or the ongoing economic and geopolitical instability on the Company’s business, results of operations, financial condition or liquidity. Future events and effects related to COVID-19 or the ongoing geopolitical instability cannot be determined with precision and actual results could significantly differ from estimates or forecasts. The Company has also seen greater volatility on foreign exchange rates. A strong dollar generally benefits the Company's supply chain activities while negatively impacting our reported international revenues. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates Preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management considers many factors in selecting appropriate financial accounting policies and controls in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgement in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the consolidated financial statements relate to share-based compensation, assessing long-lived assets for impairment, estimating the net realizable value of inventories, the determination of accounts receivables reserve, assessing goodwill for impairment, the determination of the value of trade promotions and assessing the realizability of deferred income taxes. Actual results could differ from those estimates. Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers ("ASC 606"). ASC 606 defines a five-step model that requires entities exercise judgment when considering the terms of contract(s), which include (1) identifying the contract or agreement with a customer, (2) identifying the performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. Revenue is recognized when control of the promised good is transferred to the customer in an amount that reflects the consideration to which the Company is expected to be entitled to receive in exchange for those products. Each contract includes a single performance obligation to transfer control of the product to the customer. For the Company’s various products in the Vita Coco Coconut Water and Other product categories (refer to Note 3, Revenue Recognition ), control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue. The transaction price recognized reflects the consideration the Company expects to receive in exchange for the sale of the product. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that would meet the criteria for a distinct good or service that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent fulfillment costs, which are included in cost of goods sold, rather than revenue. Additionally, the Company determined the production and distribution of Private Label products represents a distinct performance obligation. Since there is no alternative use for these products and the Company has the right to payment for performance completed to date, the Company recognizes the revenue for the production of these Private Label products over time as the production for open purchase orders is completed, which may be prior to any shipment. The resulting contract assets are recorded in prepaid expenses and other current assets. The Company provides trade promotions to its customers. These discounts do not meet the criteria for a distinct good or service and therefore, the Company reduces revenue for the discounts associated with meeting this obligation based on the expected value method. These consolidated financial statements include trade promotion accruals. Trade promotion accruals are made for invoices that have not yet been received as of year-end and are recorded as a reduction of sales. This promotion accrual is a management estimate based upon the known price of retail promotions and estimates of the sales volume during the promotion period. Cost of Goods Sold Costs of goods sold includes the costs of the products sold to customers, inbound and outbound shipping and handling costs, freight and duties, shipping and packaging supplies, and warehouse fulfillment costs incurred in operating and staffing warehouses. Shipping and Handling Costs Shipping and handling costs related to the sale of inventory represent outbound distribution costs, and are included in cost of goods sold in the consolidated statement of operations. Shipping and handling costs were $13,387, $9,331 and $7,353 for the years ended December 31, 2022, 2021, and 2020, respectively. Advertising Expenses Advertising expenses are charged to expense in the period they are incurred and are recorded in selling, general and administrative expenses. Advertising expenses were $14,404, $13,755, and $12,862 for the years ended December 31, 2022, 2021 and 2020, respectively. Research and Development Research and development costs are charged to expense in the period incurred and are recorded in selling, general and administrative expenses. Research and development expenses were $541, $477, and $313 for the years ended December 31, 2022, 2021 and 2020, respectively. Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation — Stock Compensation ("ASC 718") for awards issued under the 2014 Stock Option and Restricted Stock Plan and the 2021 Stock Incentive Award Plan. The Company measures all awards based on their fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period of each stock award grant, which is generally the vesting period of the respective award by using the accelerated attribution method. The Company applies an estimated forfeiture rate derived from historical employee termination behavior. If the actual forfeitures differ from those estimated by management, adjustment to compensation expense may be required in future periods. The Company issues stock-based awards with service-based and performance-based and market-based vesting conditions. The Company recognizes expense for performance-based awards when it becomes probable that such awards will be earned over a requisite service period. The Company defers the recognition of compensation expense for the stock awards that vest upon qualifying liquidity events until the qualifying events are probable of occurrence. Stock awards are equity-classified, as they do not contain a cash settlement option or other features requiring them to be liability-classified. The Company uses the Black-Scholes option-pricing model to determine the fair value of stock awards with service-based vesting conditions and performance-based vesting conditions. For stock awards with performance-based and market-based vesting conditions, the Company uses the Barrier option valuation model to determine the fair value. The Company has classified most of its stock-based compensation expense in its consolidated statements of operations in selling, general, and administrative expenses, reflecting the same manner in which the award recipient’s payroll costs are classified or in which the award recipient’s service payments are classified. There are restricted stock units previously granted to entities affiliated with a major customer, which was recognized as a stock-based sales incentive based on guidance in ASC 606 and reflected as a reduction in the transaction price revenue. See Note 14, Stockholders' Equity for further information. Income Taxes The Company accounts for income taxes under ASC 740, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for differences between the consolidated financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future. Such deferred income tax assets and liabilities computations are based on enacted tax laws and rates applicable to periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred income tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax positions are included in income tax expense in the consolidated statement of operations and comprehensive income and accrued expenses in the consolidated balance sheets. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Net Income per Common Share In accordance with ASC Topic 260 Earnings Per Share ("ASC 260"), net income per common share, on a basic and diluted basis, is presented for all periods, calculated using the treasury stock method. Basic net income per share is computed by dividing net income by the weighted average number of common shares and service warrants outstanding during each period. Diluted net income per share is computed by dividing net income by the weighted average number of common and dilutive common equivalent shares outstanding. The calculation of common equivalent shares assumes the exercise of dilutive in-the-money stock options, net of assumed treasury share repurchases at average market prices, as applicable. Cash and Cash Equivalents Cash and cash equivalents include cash on hand and money market instruments with maturities of three months or less. Accounts Receivable Accounts receivable are reported net of an allowance for doubtful accounts. In determining such an allowance, the Company considers historical losses and existing economic conditions, as well as the credit quality of each customer. Accounts receivable are charged off when the Company deems amounts to be uncollectible. Inventory Inventory represents raw materials, finished goods, packaging, and inbound shipping and handling and is reported at the lower of cost or net realizable value being determined using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company reserves for finished goods that are close to the date of expiration. Deferred Offering Costs The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings as deferred offering costs until such financings are consummated. After consummation of an equity financing, these costs are recorded in stockholders’ equity as a reduction of additional paid-in capital generated as a result of the offering. If an in-process equity financing is abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the consolidated statements of operations. As a result of the completion of the IPO on October 25, 2021 as described in Note 1, deferred offering costs recorded during the period were netted against the proceeds of the offering and reflected as a component of additional paid-in-capital in the quarter ended December 31, 2021. As of December 31, 2022 and 2021, the Company had no deferred offering costs in the consolidated balance sheets. Property and Equipment Property and equipment are stated at cost and are depreciated over the estimated useful lives of the related assets or in the case of leasehold improvements, the lease term if shorter, using the straight-line method of depreciation. Repairs and maintenance are charged to expense as incurred. The estimated useful lives of the Company’s property and equipment are as follows: • Equipment and computer software and hardware – 3-7 years • Leasehold improvements – The lesser of the life of the asset or the term of the lease • Vehicles – 5 years • Furniture and fixtures – 3-5 years Impairment of Long-Lived Assets The Company evaluates the recoverability of its long-lived assets, principally intangibles and property and equipment, by comparing asset group’s carrying value to the expected undiscounted future cash flows to be generated from such assets when events or circumstances indicate that an impairment may have occurred. If the estimated undiscounted future cash flows are less than the carrying amount, an impairment loss is recorded based upon the difference between the carrying amount and the fair value of the asset. Acquisitions The Company evaluates each of its acquisitions under the accounting framework in Accounting Standards Codification Topic 805, Business Combinations ("ASC 805"). ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired, the liabilities assumed and any non-controlling interest in the acquired entity, and recognize and measure goodwill or a gain from the purchase. The acquiree’s results are included in the consolidated financial statements from the date of the acquisition. The Company allocated the purchase price, including the fair value of any non-cash and contingent consideration, to the identifiable assets and liabilities of the relevant acquired business at their acquisition date fair values. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill. Contingent consideration payable in cash or a fixed dollar amount settleable in a variable number of shares is classified as a liability and recorded at fair value, with changes in fair value recorded as a component of operating expenses in the accompanying consolidated statements of operations. Transaction costs associated with business combinations are expensed as incurred and are included in selling, general and administrative expense in the consolidated statements of operations. The Company performs valuations of assets acquired, liabilities assumed, and contingent consideration and allocates the purchase price to its respective assets and liabilities. Determining the fair value of assets acquired, liabilities assumed, and contingent consideration requires the use of significant judgment and estimates including the selection of valuation methodologies, estimates of future revenue, costs and cash flows, discount rates, the probability of the achievement of specified milestones, and selection of comparable companies. The Company engages the assistance of valuation specialists in concluding on fair value measurements in connection with determining fair values of assets acquired, liabilities assumed, and contingent consideration in a business combination. Intangible assets Intangible assets consist primarily of acquired trade names and distributor relationships. The Company determines the appropriate useful life of the intangible assets by performing an analysis of expected cash flows of the acquired assets. Intangible assets are amortized over their estimated useful lives of ten years, using the straight-line method, which approximates the pattern in which the economic benefits are consumed. The Company’s intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable, or a triggering event. When a triggering event is identified, a test of recoverability is performed by estimating the undiscounted future cash flows associated with such assets and comparing them to the carrying value of the asset. When the recoverability test fails, the Company measures the impairment loss based on the fair value of the assets compared to the carrying amount of the asset. The fair value of the trade names is determined through an income approach using the relief from royalty method. The fair value of the distributor relationships is determined through an income approach using the excess earnings method. Goodwill Goodwill represents the excess of the purchase price paid in excess of the fair value of net identifiable tangible and intangible assets acquired in a business combination and is measured in accordance with the provisions of ASC 350, Intangibles – Goodwill and Other ("ASC 350"). Goodwill is not amortized; instead goodwill is tested for impairment on an annual basis on December 31, or more frequently if the Company believes indicators of impairment exist. The Company has determined that there are three reporting units for purposes of testing goodwill for impairment: (i) the Americas reporting unit, (ii) the Europe reporting unit, and (iii) the Asia reporting unit. All of the Company’s goodwill is allocated to the Americas reporting unit. The Company first assesses qualitative factors to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. In performing the qualitative assessment, the Company reviews factors both specific to the reporting units and to the Company as a whole, such as financial performance, macroeconomic conditions, industry and market considerations, and the fair value of each reporting unit at the last valuation date. If the Company elects this option and believes, as a result of the qualitative assessment, that it is more likely than not that the carrying value of each of the reporting units exceeds their fair value, the quantitative impairment test is required; otherwise, no further testing is required. Alternatively, the Company may elect to bypass the qualitative assessment and perform the quantitative impairment test instead, or if the Company reasonably determines that it is more-likely-than-not that the fair value is less than the carrying value, the Company performs its annual, or interim, goodwill impairment test by comparing the fair value of each of the reporting units with their carrying amount. The fair value of each of the reporting units is estimated by blending the results from the income approach and the market multiples approach. These valuation approaches consider a number of factors that include, but are not limited to, expected future cash flows, growth rates, discount rates, and comparable multiples from publicly-traded companies in the Company’s industry, and require to make certain assumptions and estimates regarding industry economic factors and future profitability of the Company’s business. It is the Company’s policy to conduct impairment testing based on its most current business plans, projected future revenues and cash flows, which reflect changes anticipated in the economy and the industry. The cash flows are based on five-year financial forecasts developed internally by management and are discounted to a present value using discount rates that properly account for the risk and nature of the respective reporting unit’s cash flows and the rates of return market participants would require to invest their capital in the Company’s reporting unit. The Company will recognize an impairment for the amount by which the carrying amount exceeds a reporting unit’s fair value. For the years ended December 31, 2022, 2021 and 2020, there were no impairments recorded. Supplier Advances The Company issues advances to certain manufacturers with interest at rates between 0% and 4% with terms extending to February 2028 . These advances are assessed for collectability and an allowance for credit losses is recognized when it is probable that the Company will be unable to collect all amounts due according to the contractual terms. There was no allowance recorded as of December 31, 2022 and December 31, 2021. Foreign Currency The Company’s reporting currency is the U.S. dollar. The Company maintains the financial statements of each entity within the group in its local currency, which is also the entity’s functional currency. Gains and losses on transactions denominated in currencies other than the functional currency are included in determining net income for the period. All assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenue and expenses are translated at the average exchange rate applicable during the period. Translation gains and losses are included as a component of accumulated other comprehensive income in stockholders’ equity. Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included as a component of other income (expense) in the accompanying consolidated statements of operations when incurred. Derivative Instruments The Company periodically enters into forward foreign currency exchange contracts to hedge its foreign currency exposure. The fair value of these contracts is recorded in the consolidated balance sheets with a corresponding adjustment to the consolidated statements of operations for the change in fair value of the derivative instruments, as the contracts have not been designated as a hedge instrument. Refer to Note 12, Derivative Instruments, for more information. Segment Information The Company operates as two operating and reportable segments: (i) Americas segment, which is comprised of the Company’s operations in the Americas region, primarily in the U.S. and Canada, and (ii) International segment, which is comprised of the Company’s operations primarily in Europe, Middle East, Africa and the Asia Pacific regions. The Company’s Chief Executive Officer, as the chief operating decision maker (CODM), manages and allocates resources between the Americas and International segments. Consistent with this decision-making process, the CEO uses financial information disaggregated between the Americas and International segment for purposes of evaluating performance, forecasting future period financial results, allocating resources and setting incentive targets. The CEO evaluates segment business performance based primarily on net sales and gross profit. Concentration of Credit Risk The Company’s cash and accounts receivable are subject to concentrations of credit risk. The Company’s cash balances are primarily on deposit with banks in the U.S. which are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $250. At times, such cash may be in excess of the FDIC insurance limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions and any excess cash above a certain minimum balance could be invested in overnight money market treasury deposits in widely diversified accounts. Substantially, all of the Company’s customers are either wholesalers or retailers of beverages. A material default in payment, a material reduction in purchase from these or any large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company’s financial condition, results of operations, and liquidity. The Company is exposed to concentration of credit risk from its major customers for which two customers represented 54%, 53%, and 54% of total net sales during the years ended December 31, 2022, 2021 and 2020, respectively. In addition, the two customers also accounted for 39% and 37% of total accounts receivable as of December 31, 2022 and 2021, respectively. The Company has not experienced credit issues with these customers. Recently Adopted Accounting Pronouncements In August 2018, the Financial Accounting Standards Board ("FASB") issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40). The update is associated with customer’s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. The standard aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amendments in this update require that a customer in a hosting arrangement that is a service contract follow the guidance in Subtopic 350-40 to determine which implementation costs should be capitalized as an asset and which costs should be expensed and states that any capitalized implementation costs should be expensed over the term of the hosting arrangement. The guidance is effective for the Company for fiscal years beginning after December 15, 2020, and interim periods within annual periods beginning after December 15, 2021. The Company adopted the guidance in this amendment using a prospective approach effective January 1, 2021 for the fiscal year ended December 31, 2021. The adoption of ASU 2018-15 did not have a material impact on the consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), (“ASU 2019-12”) that simplify the accounting for income taxes by removing certain exceptions for recognizing deferred taxes for investments, performing intra-period allocation and calculating incomes taxes in interim periods. ASU 2019-12 also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of consolidated group. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements. In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance , which requires disclosure about certain government assistance they receive. ASU 2021-10 is effective for all entities for annual periods beginning after December 15, 2021. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This ASU should be applied prospectively to acquisitions occurring on or after the effective date of December 15, 2022, and early adoption is permitted. The Company adopted this standard for all prospective acquisitions after the effective date. In February 2016, the FASB issued ASC 842 , ASU 2016-02 , Leases (Topic 842), which was amended by subsequent Accounting Standard Updates ("ASUs"), to enhance the comparability and usefulness of financial reporting around leasing activity. The new standard supersedes the existing authoritative literature for lease accounting under ASC 840 , with a focus on applying a “right-of-use model.” The guidance for leases under ASC 842 results in a right-of-use asset (“ROU asset”) and lease liability being reported on the balance sheet for leases with a lease term greater than twelve months. In June 2020, the FASB issued ASU 2020-05 , Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842): Effective Dates for certain entities, which deferred the effective date of ASU 2016-02 for certain entities. ASC 842 is effective for the Company, as an Emerging Growth Company (“EGC”), for annual reporting periods beginning after December 15, 2021 and for interim periods beginning after December 15, 2022. The Company adopted the standard on January 1, 2022 using the alternative modified retrospective transition approach in accordance with ASU 2018-11 , Leases (Topic 842): Targeted Improvements, where the adoption date represents the initial date of application. As part of its adoption, the Company elected to apply the package of practical expedients requiring no reassessment of whether any expired or existing contracts are or contain leases, the lease classification of any expired or existing leases, or the capitalization of initial direct costs for any existing leases. Additionally, the Company elected the practical expedient that permits the exclusion of leases considered to be short-term. Under the alternative modified retrospective transition approach, the reported results for 2022 reflect the application of ASC 842 guidance, whereas comparative periods and the respective disclosures prior to the adoption of ASC 842 are presented using the legacy guidance of ASC 840 . As a result of adopting the new standard, the Company recognized right-of-use assets and lease liabilities of $1,866 and $2,097, respectively, on the Company’s consolidated balance sheet Recently Issued Accounting Pronouncements As a company with less than $1.07 billion of revenue during the last fiscal year, the Company qualifies as an “emerging growth company”, as defined in the Jumpstart Our Business Startups Act. This classification allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use the adoption dates applicable to private companies. As a result, the Company’s financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective date for new or revised accounting standards that are applicable to public companies. In June 2016, the FASB issued ASU 2016-13 Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods with those fiscal years, for nonpublic entities. Early adoption is permitted. This standard will be effective for the Company in the first quarter of its fiscal year ending December 31, 2023. The Company is assessing the impact of adoption on the consolidated financial statements, but does not expect the adoption of this standard to have a material impact on the Company's consolidated financial statements. |
Revenue Recognition
Revenue Recognition | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | REVENUE RECOGNITION Revenues are accounted for in accordance with ASC 606. The Company disaggregates revenue into the following product categories: • Vita Coco Coconut Water – This product category consists of all branded coconut water product offerings under the Vita Coco labels, where the majority ingredient is coconut water. The Company determined that the sale of the products represents a distinct performance obligation as customers can benefit from purchasing the products on their own or together with other resources that are readily available to the customers. For these products, control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue. • Private Label – This product category consists of all private label product offerings, which includes coconut water and oil. The Company determined the production and distribution of private label products represents a distinct performance obligation. Since there is no alternative use for these products and the Company has the right to payment for performance completed to date, the Company recognizes the revenue for the production of these private label products over time as the production for open purchase orders occurs, which may be prior to any shipment. • Other – This product category consists of all other products, which includes Runa, Ever & Ever and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling , coconut milk products, and other revenue transactions (e.g., bulk product sales). For these products, control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue. The Company excludes from revenues all taxes assessed by a governmental authority that are imposed on the sale of its products and collected from customers. Disaggregation of Revenue The following table disaggregates net revenue by product type and reportable segment: December 31, 2022 Americas International Consolidated Vita Coco Coconut Water $ 275,964 $ 38,570 $ 314,534 Private Label 88,173 12,855 101,029 Other 9,485 2,740 12,224 Total $ 373,622 $ 54,165 $ 427,787 December 31, 2021 Americas International Consolidated Vita Coco Coconut Water $ 231,858 $ 34,639 $ 266,497 Private Label 80,639 14,007 94,646 Other 11,394 6,976 18,370 Total $ 323,891 $ 55,622 $ 379,513 December 31, 2020 Americas International Consolidated Vita Coco Coconut Water $ 164,786 $ 27,167 $ 191,953 Private Label 83,449 12,596 96,045 Other 14,664 7,982 22,646 Total $ 262,899 $ 47,745 $ 310,644 |
Accounts Receivable, Net
Accounts Receivable, Net | 12 Months Ended |
Dec. 31, 2022 | |
Receivables [Abstract] | |
Accounts Receivable, Net | ACCOUNTS RECEIVABLE, NET Accounts receivable, net was $43,350 and $47,195 as of December 31, 2022 and 2021, respectively. The Company recorded an allowance for doubtful accounts of $2,898 and $1,301 as of December 31, 2022 and 2021, respectively. Changes in the allowance for doubtful accounts for the periods presented were as follows: Balance at January 1, 2021 $ 1,211 Provision charged to operating results 76 Account write-offs and other deductions, net of recoveries 14 Balance as of December 31, 2021 $ 1,301 Provision charged to operating results 2,641 Account write-offs and other deductions, net of recoveries (1,044) Balance as of December 31, 2022 $ 2,898 |
Inventory
Inventory | 12 Months Ended |
Dec. 31, 2022 | |
Inventory Disclosure [Abstract] | |
Inventory | INVENTORY Inventory consists of the following: December 31, 2022 2021 Raw materials and packaging $ 5,771 $ 4,868 Finished goods 78,344 70,492 Inventory $ 84,115 $ 75,360 |
Prepaid Expenses and Other Curr
Prepaid Expenses and Other Current Assets | 12 Months Ended |
Dec. 31, 2022 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Prepaid Expenses and Other Current Assets | PREPAID EXPENSES AND OTHER CURRENT ASSETSPrepaid expenses and other current assets consist of the following: December 31, 2022 2021 Tax receivables $ 527 $ 2,946 Contract assets 10,337 2,627 VAT receivables 1,054 1,436 Supplier prepaid 4,018 6,182 Prepaid insurance 1,701 2,530 Other prepaid expenses 2,254 2,614 Other receivables 2,290 2,383 $ 22,181 $ 20,718 |
Property and Equipment, Net
Property and Equipment, Net | 12 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment, Net | PROPERTY AND EQUIPMENT, NET Property and equipment, net consist of the following: December 31, 2022 2021 Equipment and computer software and hardware $ 5,137 $ 4,604 Leasehold improvement 339 503 Vehicles 784 820 Land and improvements — 506 Furniture and fixtures 401 321 Total Property Plant & Equipment 6,661 6,754 Less accumulated depreciation and amortization (4,585) (4,281) Property and equipment-net $ 2,076 $ 2,473 Depreciation expense related to property and equipment, net for the years ended December 31, 2022, 2021 and 2020 was $681, $849 and $905, respectively. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets, net consist of the following: December 31, 2022 2021 Goodwill $ 7,791 $ 7,791 December 31, 2022 December 31, 2021 Gross Carrying Accumulated Impairment Net Gross Carrying Accumulated Net Intangible assets, net Trade names $ 6,200 $ (2,807) $ (3,393) $ — $ 6,200 $ (2,187) $ 4,013 Distributor relationships 6,000 (2,717) (3,283) $ — 6,000 (2,117) 3,883 Other 38 — (38) $ — 38 — 38 Total Intangible assets subject to amortization & impairment $ 12,238 $ (5,524) $ (6,714) $ — 12,238 $ (4,304) $ 7,934 Annual Goodwill Impairment Testing All of the Company’s goodwill is associated with the acquisition of Runa , which was acquired in June 2018. The goodwill is allocated to the Americas reporting unit and is tax deductible. In assessing whether goodwill was impaired in connection with its annual impairment testing performed at December 31, 2020, the Company elected to bypass the qualitative assessment and, performed a quantitative assessment in accordance with ASC 350. Refer to Note 2, Summary of Significant Accounting Policies, for further discussion of the quantitative analysis. In December 31, 2022, the Company performed the qualitative assessment only, which did not indicate that it is more likely than not that the carrying value of each of the reporting units exceeds their fair value, resulting in no further quantitative testing. Based on the results of the annual impairment test, the Company concluded that no impairment to goodwill existed as of December 31, 2022, 2021 and 2020. Intangible Assets, net The intangible assets, net associated with the acquisition of Runa was $0 and $7,934 as of December 31, 2022 and 2021, respectively. All the intangible assets are amortized over their useful life. Since the intangibles are subject to amortization, they are reviewed for impairment in accordance with ASC 360, Property, Plant, and Equipment . Under ASC 360, long-lived assets are tested for recoverability at the asset group level whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. In step 1, the entity determines recoverability of the asset group by comparing its carrying value with the sum of its undiscounted cash flows expected to result from the use and eventual disposition of the asset group. If the sum of the undiscounted cash flows is less than the carrying value of the asset group, then step 2 must be performed, in which the entity compares the fair value of the asset group to its carrying amount. The excess of the carrying value of the asset group over its fair value, if any, would be recognized as an impairment loss. During 2022, the Company identified facts and circumstances indicating the carrying value of the intangible assets associated with Runa, including the trade names and distributor relationships, may not be recoverable, resulting in the determination that a triggering event had occurred. Based on step 1, the Company determined that the Runa intangible assets were not recoverable based on a test of recoverability using expected undiscounted future cash flows for the Runa brand in the Americas. For both trade names and distributor relationships, the Company applied step 2, by determining the fair value of these intangible assets, which concluded that the fair value was significantly below the carrying amount. Accordingly, the Company recorded an impairment charge of $6,714 for the year ended December 31, 2022, which is recorded in selling, general and administrative expense on the Company’s consolidated statements of operations. Amortization expense of $1,220 for the years ended December 31, 2022, 2021 and 2020 were included in selling, general and administrative expenses on the consolidated statements of operations. |
Accrued Expenses
Accrued Expenses | 12 Months Ended |
Dec. 31, 2022 | |
Payables and Accruals [Abstract] | |
Accrued Expenses | ACCRUED EXPENSESAccrued expenses consist of the following: December 31, 2022 2021 Accrued promotions and marketing $ 18,624 $ 19,455 Payroll and benefits related expenses 3,814 10,258 Shipping and handling costs 8,854 4,175 Accrued trade payable 1,613 1,647 Current operating lease liabilities 734 — VAT payable 1,599 2,276 Income tax payable 834 2,138 Accrued professional fees 350 628 Other accrued expenses 1,920 1,822 $ 38,342 $ 42,399 |
Debt
Debt | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | DEBT The table below details the outstanding balances on the Company’s credit facility and notes payable as of December 31, 2022 and 2021: December 31, 2022 2021 2020 Credit facility $ — $ — Notes payable Vehicle loans 48 76 $ 48 $ 76 Current $ 23 $ 28 Non-current $ 25 $ 48 2020 Credit Facility In May 2020, the Company entered into the five-year credit facility, the 2020 Credit Facility with Wells Fargo consisting of a revolving line of credit. The 2020 Credit Facility was further amended in May 2021 and October 2021, and currently provides for committed borrowings of $60 million. Borrowings on the 2020 Credit Facility bear interest at rates based on either: 1) LIBOR or 2) a specified base rate (determined by reference to the greatest of the prime rate published by Wells Fargo, the federal funds effective rate plus 1.5% and one-month LIBOR plus 1.5%), as selected periodically by the Company. The LIBOR-based loans bear interest at LIBOR plus a spread ranging from 1.00% to 1.75% per annum, with the spread in each case being based on the Company’s leverage ratio (as defined in the credit agreement) for the immediately preceding fiscal quarter as defined in the credit agreement. In addition, the Company is currently subject to an unused commitment fee ranging from 0.05% and 0.20% on the unused amount of the line of credit, with the rate being based on the Company’s leverage ratio (as defined in the credit agreement). The maturity date on the 2020 Credit Facility is May 12, 2026. In December 2022, the Company amended the 2020 Credit Facility to transition the interest rate from reference to LIBOR to the SOFR. The borrowings made after the amendment bear interest at rates based on either 1) a fluctuating rate per annum determined to be the sum of Daily Simple SOFR plus the same spread discussed above or 2) a fixed rate per annum determined to be the sum of the Term SOFR plus the same spread discussed. The spread and the commitment fees did not change as a result of this amendment. As of December 31, 2022 and December 31, 2021, the Company had no outstanding balance and $60,000 undrawn and available under its amended 2020 Credit Facility. Interest expense and unused commitment fee for the 2020 Credit Facility amounted to $255 and $51, respectively, for the year ended December 31, 2022. Interest expense and unused commitment fee for the 2020 Credit Facility amounted to $176 and $39, respectively, for the year ended December 31, 2021.The effective interest rate was 2.53% and 0.97%, respectively, as of December 31, 2022 and 2021. The 2020 Credit Facility is collateralized by substantially all of the Company’s assets. The 2020 Credit Facility contains certain affirmative and negative covenants that, among other things, limit the Company’s ability to, subject to various exceptions and qualifications: (i) incur liens; (ii) incur additional debt; (iii) sell, transfer or dispose of assets; (iv) merge with or acquire other companies, (v) make loans, advances or guarantees; (vi) make investments; (vii) make dividends and distributions on, or repurchases of, equity; and (viii) enter into certain transactions with affiliates. The 2020 Credit Facility also requires the Company to maintain certain financial covenants including a maximum leverage ratio, a minimum fixed charge coverage ratio, and a minimum asset coverage ratio. As of December 31, 2022, the Company was compliant with all financial covenants. 2021 Term Loan In May 2021, the Company entered into the 2021 Term Loan pursuant to the terms of the credit agreement entered into in connection with the 2020 Credit Facility. The 2021 Term Loan provided the Company with borrowings up to $30,000. The Company incurred interest on the 2021 Term Loan at the same rate as the 2020 Credit Facility. The Company was required to repay the principal on the 2021 Term Loan in quarterly installments commencing on October 1, 2021 through the maturity date of May 21, 2026. The 2021 Term Loan was subject to the same affirmative, negative and financial covenants as the 2020 Credit Facility. On October 27, 2021, the Company repaid the outstanding balance on the 2021 Term Loan using the net proceeds from the IPO as discussed in Note 1. In accordance with ASC 470, the Company recognized a loss of $132 related primarily to the write-off of deferred financing costs, which was recorded in the "Loss on extinguishment of debt" line in the accompanying consolidated statements of operations. Prior to entering into the 2021 Term Loan, the Company held two other Term Loans, which were paid off in connection with entering into the 2020 Credit Facility in May 2020: • 2016 Term Loan—On August 9, 2016, the Company entered into a five-year term loan with JPMorgan Chase, N.A. (“2016 Term Loan”). The total amount of the term loan was $10,000 which matured in August 2021. Principal payments were based on an increasing percentage of the initial loan amount varying from 2.5% to 5% and were made at the end of each quarter. • 2017 Term Loan—On April 25, 2017, the Company entered into a five-year term loan with JPMorgan Chase, N.A. (“2017 Term Loan 2017”). The total amount of the term loan was $15,000 which matured in April 2022. Principal payments were based on an increasing percentage of the initial loan amount varying from 2.5% to 5% and were made at the end of each quarter. The 2016 Term Loan and the 2017 Term Loan bear interest at LIBOR plus 1.50% and were collateralized by substantially all of the Company’s assets. The 2016 Term Loan and 2017 Term Loan contained certain affirmative and negative covenants that, among other things, limited the Company’s ability to, subject to various exceptions and qualifications: (i) incur liens; (ii) incur additional debt; (iii) sell, transfer or dispose of assets; (iv) merge with or acquire other companies, (v) make loans, advances or guarantees; (vi) make investments; and (vii) enter into certain transactions with affiliates. The 2016 Term Loan and 2017 Term Loan also required the Company to maintain certain financial covenants including a maximum leverage ratio and a minimum fixed charge coverage ratio. Interest expense related to the 2021, 2017, and 2016 Term Loans amounted to $141 and $188 for the years ended December 31, 2021 and 2020, respectively. Vehicle Loans The Company periodically enters into vehicle loans. Interest rate on these vehicle loans range from 4.56% to 5.68%. The Company is required to make principal payments of $2 on a monthly basis. Aggregate principal payments on the notes payable for the next five years are as follows: 2023 $ 22 2024 13 2025 10 2026 3 Total notes payable $ 48 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | COMMITMENTS AND CONTINGENCIES Contingencies: Litigation —The Company may engage in various litigation in the ordinary course of business. The Company intends to vigorously defend itself in such matters and management, based upon the advice of legal counsel, is of the opinion that the resolution of these matters will not have a material effect on the consolidated financial statements. For the cases for which management believes that it is more likely than not that it will lose the case, a provision for legal settlements has been recorded. As of December 31, 2022 and 2021, the Company has not recorded any liabilities relating to legal settlements. Business Risk —The Company imports finished goods predominantly from manufacturers located in South American and Southeast Asian countries. The Company may be subject to certain business risks due to potential instability in these regions. Major Customers —The Company’s customers that accounted for 10% or more of total net sales and total accounts receivable were as follows: Net sales Accounts receivable Year Ended December 31, December 31, 2022 2021 2020 2022 2021 Customer A 30 % 30 % 35 % 16 % 18 % Customer B 24 % 23 % 19 % 23 % 19 % One of the customers acquired less than 5% ownership in the Company upon consummation of the IPO. Major Suppliers —The Company’s suppliers that accounted for 10% or more of the Company’s purchases were as follows: Year Ended December 31, 2022 2021 Supplier A 17 % 21 % Supplier B 13 % 13 % |
Derivative Instruments
Derivative Instruments | 12 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments | DERIVATIVE INSTRUMENTS The Company accounts for derivative instruments in accordance with the ASC Topic 815, Derivatives and Hedging ("ASC 815"). These principles require that all derivative instruments be recognized at fair value on each balance sheet date unless they qualify for a scope exclusion as a normal purchase or sale transaction, which is accounted for under the accrual method of accounting. In addition, these principles permit derivative instruments that qualify for hedge accounting to reflect the changes in the fair value of the derivative instruments through earnings or stockholders’ equity as other comprehensive income on a net basis until the hedged item is settled and recognized in earnings, depending on whether the derivative is being used to hedge changes in fair value or cash flows. The ineffective portion of a derivative instrument’s change in fair value is immediately recognized in earnings. As of December 31, 2022 and December 31, 2021, the Company did not have any derivative instruments that it had designated as fair value or cash flow hedges. The Company is subject to the following currency risks: Inventory purchases from Brazilian and Malaysian manufacturers— In order to mitigate the currency risk on inventory purchases from its Brazilian and Malaysian manufacturers, which are settled in Brazilian Real ("BRL") and Thai Bhatt ("THB"), the AMS subsidiary enters into a series of forward currency swaps to buy BRL and THB. Intercompany transactions between AME and AMS— In order to mitigate the currency risk on intercompany transactions between AME and AMS, AMS enters into foreign currency swaps to sell GBP. Commercial transactions with Canadian customer and vendors— In order to mitigate the currency risk on transactions with Canadian customer and vendors, the Company enters into foreign currency swaps to sell Canadian Dollars ("CAD"). The notional amount and fair value of all outstanding derivative instruments in the consolidated balance sheets consist of the following at: December 31, 2022 Derivatives not designated as hedging instruments under ASC 815-20 Notional Fair Value Balance Sheet Location Assets Foreign currency exchange contracts Receive USD/pay GBP $ 23,702 $ 1,104 Derivative assets Receive BRL/sell USD 46,301 2,314 Derivative assets Receive USD/pay CAD $ 4,819 $ 188 Derivative assets Liabilities Foreign currency exchange contracts Receive USD/pay EUR $ 604 $ (7) Derivative liabilities Receive THB/sell USD 21,990 (64) Derivative liabilities December 31, 2021 Derivatives not designated as hedging instruments under ASC 815-20 Notional Fair Value Balance Sheet Location Assets Foreign currency exchange contracts Receive USD/pay GBP $ 22,323 $ 125 Derivative assets Receive MYR/sell USD $ 392 $ 1 Derivative assets Liabilities Foreign currency exchange contracts Receive BRL/sell USD $ 43,174 $ (2,389) Derivative liabilities Receive USD/pay CAD 4,731 (57) Derivative liabilities Receive THB/sell USD 18,488 (751) Derivative liabilities The amount of realized and unrealized gains and losses and consolidated statements of operations and comprehensive income location of the derivative instruments as of December 31, 2022 and 2021 are as follows: 2022 2021 2020 Unrealized gain (loss) on derivative instruments $ 6,606 $ 2,093 $ (4,718) Location Unrealized gain on derivative instruments Unrealized gain on derivative instruments Unrealized (loss) on derivative instruments Foreign currency gain (loss) $ 2,682 $ (5,679) $ 6,765 Location Foreign currency gain Foreign currency (loss) Foreign currency gain The Company applies recurring fair value measurements to its derivative instruments in accordance with ASC Topic 820, Fair Value Measurements ("ASC 820"). In determining fair value, the Company used a market approach and incorporates the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable internally developed inputs. |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | FAIR VALUE MEASUREMENTS ASC 820 provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs. Based upon observability of the inputs used in valuation techniques, the Company’s assets and liabilities are classified as follows: • Level 1— Quoted market prices in active markets for identical assets or liabilities. • Level 2— Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted market prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. • Level 3— Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes internally developed models and methodologies utilizing significant unobservable inputs. Forward currency swap contracts— The Company’s valuation methodology for forward currency swap contracts is based upon third-party institution data. Contingent consideration liability— The Company utilized a probability weighted scenario-based model to determine the fair value of the contingent consideration. The Company’s fair value hierarchy for those assets (liabilities) measured at fair value on a recurring basis at December 31, 2022 and 2021, is as follows: Level 1 Level 2 Level 3 Total 2022 $ — $ 3,535 $ — $ 3,535 2021 $ — $ (3,071) $ — $ (3,071) In connection with the Company’s acquisition of the entity currently known as AMI Runa USA LLC ("Runa") , the Company was obligated to pay contingent payments to Runa’s former shareholders only if a certain growth rate is achieved. Assuming the revenue growth is achieved, the former shareholders could elect for payment to be calculated based on quarterly data available between December 2021 and December 2022, as follows: 49% of the product of (a) the net revenue for the trailing 12 calendar months and (b) a specified multiple, which is contingent on the revenue growth achieved since December 31, 2017. Per the acquisition agreement, the contingent payment cannot exceed $51,500. If a certain revenue growth rate is not achieved during the remeasurement period, the Company is not required to pay any contingent payment. The term of the remeasurement period under the agreement ended in December 2022. The fair value of contingent consideration of $15,700 determined on the acquisition date in 2018 was initially recognized as a liability and then subsequently remeasured to fair value at each reporting date with changes in fair value recognized as a component of operating expenses in the accompanying consolidated statements of operations. The contingent consideration liability related to the acquisition of Runa was considered a Level 3 liability, as the fair value was determined based on significant inputs not observable in the market, and recorded within other long-term liabilities in the accompanying consolidated balance sheets. The Company estimated the fair value of the contingent consideration liability based on a probability-weighted present value of various future cash payment outcomes using a Monte Carlo simulation. The technique considered the following unobservable inputs as of each valuation date: • The probability and timing of achieving the specified milestones, • Revenue performance expectations, and • Market-based discount rates. Based on updated revenue performance expectations during the earn-out period for Runa, the Company remeasured the contingent consideration to zero at December 31, 2021 and at December 31, 2022. There were no transfers between any levels of the fair value hierarchy for any of the Company’s fair value measurements. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | STOCKHOLDERS’ EQUITY Common and Treasury Stock — Each share of common stock entitles its holder to one vote on matters required to be voted on by the stockholders of the Company and to receive dividends, when and if declared by the Company’s board of directors. As of December 31, 2022 and 2021, the Company held 6,206,200 shares in treasury stock and had 2,898,930 and 3,434,312 shares, respectively, of common stock reserved for future issuance upon the conversion of outstanding warrants and stock options. In January 2021, the Company entered into a Stock Purchase Agreement with RW VC S.a.r.l, f/k/a Vita Coco S.a.r.l (the “Seller”). The Company repurchased 5,192,005 shares of its own common stock from the Seller at a purchase price of $9.63 per share, or an aggregate purchase price of approximately $50,000. The purchase price per share approximated the most recent third-party common stock valuation prepared in conjunction with the accounting of stock-based compensation discussed within this Note. Non-controlling Interest —On August 17, 2021, the Company’s ownership interest in AME increased as a result of the subsidiary AME repurchasing AME shares from certain minority stockholders. As a result, the noncontrolling interest in AME representing minority stockholders’ proportionate share of the equity in AME was reduced from 1.3% to 0.71%. On December 31, 2021, the Company purchased the remaining outstanding AME shares directly from minority stockholders by exchanging shares in the Company on the basis of 5.485 Vita Coco shares being allotted for every 1 AME share. The share ratio exchange reflects a mutually agreed valuation of AME shares relative to Vita Coco shares. Since the Company continued to retain a controlling financial interest in AME, the change in ownership interest was accounted for as an equity transaction. Warrants — All service warrants were exercised and exit warrants were expired as of December 31, 2021. As such, there was no warrant activity for the year ended December 31, 2022. Stock-based Compensation — The stockholders of the Company approved the adoption of the Company’s 2014 Stock Option and Restricted Stock Plan (the “2014 Plan”). The 2014 Plan allowed for a maximum of 8% of the sum of the Available Equity defined as the sum of (i) the total then outstanding shares of common shares and (ii) all available stock option (i.e., granted and outstanding stock options and stock options not yet granted). Under the terms of the 2014 Plan, the Company may grant employees, directors, and consultants stock options and restricted stock awards and has the authority to establish the specific terms of each award, including exercise price, expiration, and vesting. Currently, only stock options were granted under the 2014 Plan. Generally, stock options issued pursuant to the 2014 Plan must contain exercise prices no less than the fair value of the Company’s common stock on the date of grant and have a ten-year contractual term. Subsequent to September 30, 2021, the stockholders of the Company approved the adoption of the 2021 Incentive Award Plan ("2021 Plan"), which became effective after the closing of the IPO discussed in Note 1. On and after closing of the offering and the effectiveness of the 2021 Incentive Award Plan, no further grants will be made under the 2014 Plan. The maximum number of shares of our common stock available for issuance under the 2021 Plan is equal to the sum of (i) 3,431,312 shares of our common stock and (ii) an annual increase on the first day of each year beginning in 2022 and ending in and including 2031, equal to the lesser of (A) two percent (2%) of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year and (B) such lesser amount as determined by our board of directors; provided, however, no more than 3,431,312 shares may be issued upon the exercise of incentive stock options, or ISOs. The 2021 Plan provides for the grant of stock options, including ISOs and nonqualified stock options, or NSOs, restricted stock, dividend equivalents, stock payments, restricted stock units, or RSUs, other incentive awards, SARs, and cash awards. Currently, stock options, restricted stock, and RSU's were granted under 2021 Plan. As of December 31, 2022, there were 2,898,930 shares of common stock reserved for future issuance pursuant to the 2021 Plan. The Company recognized stock-based compensation expense of $6,134, $3,103 and $1,517 for the years ended December 31, 2022, 2021 and 2020, respectively in selling, general, and administrative expenses. The Company also recognized a reduction of revenue of $1,250 and $277 for the years ended December 31, 2022 and 2021 related to stock-based compensation awards granted to entities affiliated with a major customer that was accounted for as a stock-based sales incentive. The total impact to additional paid-in capital related to stock-based compensation arrangements in 2022 and 2021 were $7,384 and $3,380, respectively. Stock Option Awards with Service-based Vesting Conditions Most stock option awards granted under the 2014 and 2021 Plans vest based on the continuous service. The stock options awarded to the employees have different vesting schedules as specified in each grant agreement. Generally, the majority of the outstanding stock options vest 50% over the two years and 50% vest over the four years. The following table summarizes the service-based stock option activity during the year ended December 31, 2022: Number of Weighted- Weighted- Aggregate (per option) (in years) (in thousands) Outstanding—December 31, 2021 4,117,671 $ 10.34 Granted 128,940 15.36 Exercised 370,940 8.36 Forfeited 161,697 11.27 Outstanding—December 31, 2022 3,713,974 $ 11.00 7.0 $ 10,062 Exercisable—December 31, 2022 2,129,042 $ 10.29 6.7 $ 7,522 The weighted average grant-date fair value of the service-based stock option awards granted during the years ended December 31, 2022 and 2021 was $6.98 per option and $5.62 per option, respectively. The aggregate intrinsic value of service-based stock options exercised was $2,026 and $66 for the years ended December 31, 2022 and 2021, respectively. The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for all stock options that had exercise prices lower than the fair value of the Company’s common stock. In December 2019, the board of directors of the Company approved a one-time repricing of 1,877,785 outstanding service-based stock options for 53 grantees. In addition, the Company extended the expiration date of the modified stock options with the contractual term being 10 years from the date of the modification, while all other modified option terms remained the same. The fair value of the service-based stock options granted in 2022 and 2021 pursuant to the Stock Option Plan as well as the fair value of the modified in 2019 stock options was estimated on a grant or on a modification date using the Black-Scholes option-pricing model. The weighted average assumptions used in the Black-Scholes option-pricing model were as follows: 2022 2021 Weighted average expected term 7.00 years 6.3 years Weighted average expected volatility 39 % 39 % Weighted average risk-free interest rate 2.86 % 1.19 % Weighted average expected dividend yield 0 % 0 % Expected Term: Represents the period that the stock-based awards are expected to be outstanding based on a contractual term and service conditions specified for the awards. The Company estimated the expected term of the options with service conditions in accordance with the “simplified” method as defined in ASC 718, which enables the use of a practical expedient for “plain vanilla” share options. Expected Volatility : The Company has historically been a private company and lacks company-specific historical and implied volatility information for its stock. Therefore, the Company estimated volatility for option grants by evaluating the average historical volatility of a peer group of companies for the period immediately preceding the option grant for a term that is approximately equal to the expected term of the options. Risk-free Interest Rate: The risk-free interest rate was based on the yield, as of the option valuation date, by reference to the U.S. Treasury yield curve in effect at the time of the grant or the modification of the award for time periods equal to the expected term of the award. Dividend Yield —The Company does not anticipate declaring a dividend over the expected term. As such, the dividend yield has been estimated to be zero. Fair Value of Common Stock — For stock awards granted subsequent to the IPO, the fair value of the common stock assumed for the grant date fair value of the awards will be based on the closing price of our common stock as reported on the day of grant. Prior to the IPO in October 2021, because there has been no public market for the Company’s common stock, the board of directors has determined the estimated fair value of the common stock at the time of grant of options by considering valuations performed by an independent third-party valuation specialist, which considers a number of objective and subjective factors including valuations of comparable companies, operating and financial performance, the lack of liquidity of capital stock, the likelihood of achieving an initial public offering and general and industry specific economic outlook. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants’ Accounting and Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation . The third-party common stock valuations were prepared using a combination of the income approach and market approach. As of December 31, 2022, there was $4,425 of total unrecognized compensation cost related to unvested service-based stock options, which is expected to be recognized over a weighted-average service period of 2.2 Years. Stock Option Awards with Performance and Market-based Vesting Conditions During the year ended December 31, 2021, the Company awarded options for the purchase 262,990 shares of common stock of the Company containing a performance-based vesting condition, subject to achievement of various performance goals by the end of 2027, including revenue and gross margin targets. In addition, during the year ended December 31, 2021, the Company awarded options to purchase 68,250 shares of common stock of the Company containing performance and market vesting conditions, such as option vesting upon occurrence of an initial public offering or other qualifying liquidity event and upon achieving predetermined equity value of the Company at a time of the initial public offering or other qualifying liquidity event. During the year ended December 31, 2022, certain awards that contained a performance-based vesting condition were modified. The modification adjusted the performance condition to allow for 50% of the performance awards to meet the criteria to vest, and no other terms were modified. Since it did not affect any terms that would affect the fair value, and only the number of awards, it is considered an improbable-to-probable modification. The impact of the modification was not material. The following table summarizes the stock option activity during the year ended December 31, 2022: Number of Weighted- Weighted- Aggregate (per option) (in years) (in thousands) Outstanding—December 31, 2021 778,960 $ 10.33 Granted 38,675 10.18 Exercised — — Forfeited 9,100 10.18 Outstanding—December 31, 2022 808,535 $ 10.32 6.9 $ 2,658 None of the stock options included in the table above are exercisable at December 31, 2022. The fair value of the awards with performance-based vesting condition was estimated using the Black-Scholes option-pricing model used for the Company’s service-based stock options and assumed that performance goals will be achieved. If such performance conditions are not met, no compensation cost is recognized and any recognized compensation cost is reversed. The grant-date fair value of the stock options with performance-based vesting condition granted during the years ended December 31, 2021 and 2020 was $4.38 per option and $4.56 per option, respectively. The Company has not granted any performance based options for the year ended December 31, 2022 other than the modified awards noted above. In December 2020, the board of directors of the Company approved a one-time modification of the options to purchase 579,670 shares of common stock containing both a performance and market vesting conditions to reduce the equity value required to be achieved at the time of the IPO or other qualifying liquidity event. All other option terms remained the same. In connection with the modification, the Company revalued the options using a Barrier option valuation model which resulted in a fair value of $2.11 per option. There was no incremental compensation expense recognized in connection with the modification during the year ended December 31, 2021, as the attainment of the performance and market vesting conditions was not probable. The assumptions used to revalue the performance and market-based stock option grants were as follows: Weighted average expected term 2.44 years Weighted average expected volatility 40 % Weighted average risk-free interest rate 0.16 % Weighted average expected dividend yield 0 % Expected Term: The period of time for which the stock option awards are expected to be outstanding until exercise and considers time until expected liquidity event. Expected Volatility : The Company has historically been a private company and lacks company-specific historical and implied volatility information for its stock. Therefore, the Company estimated volatility for option grants by evaluating the average historical volatility of a peer group of companies for the period immediately preceding the option grant for a term that is approximately equal to the expected term of the options. Risk-free Interest Rate: The risk-free interest rate is based on the yield, as of the option valuation date, by reference to the U.S. Treasury yield curve in effect at the time of the grant or the modification of the award for time periods equal to the expected term of the award. Dividend Yield —The Company does not anticipate declaring a dividend over the expected term. As such, the dividend yield has been estimated to be zero. As of December 31, 2022, total unrecognized compensation cost related to the unvested stock option awards containing performance and market vesting conditions was $1,606, which is expected to be recognized over the period of approximately 4.22 years. As of December 31, 2021, the unrecognized stock-based compensation cost related to the stock options for which performance-based vesting conditions are probable of being achieved was $403, which is expected to be recognized over the period of approximately 3.18 years. As of December 31, 2021, total unrecognized compensation cost related to the unvested stock option awards containing performance and market vesting conditions was $1,599, which will be recognized when attainment of the performance and market vesting conditions becomes probable. Restricted Stock and Restricted Stock Unit Awards ("RSUs") Restricted stock and RSUs were granted under the 2021 Plan and primarily vest based on continuous service. Currently, there is no restricted stock or RSUs that contain any performance or market conditions. The RSUs awarded to the employees have different vesting schedules as specified in each grant agreement. The RSUs granted to non-employee directors vested in full on the earlier of (i) the day immediately preceding the date of the first Annual Meeting following the date of grant and (ii) the first anniversary of the date of grant. The following table summarizes the restricted stock and RSU activity for the year ended December 31, 2022: Number of Restricted Stock or RSU Awards Weighted Average Grant Date Fair Value Non-vested - December 31, 2021 454,881 $ 15.00 Granted 342,637 $ 12.97 Vested 89,728 $ 15.00 Forfeited/Cancelled 41,613 $ 13.12 Non-vested - December 31, 2022 666,177 $ 14.08 Also included in these awards are $3 million of shares of restricted common stock granted to entities affiliated with a significant customer, at a price per share granted at the initial public offering price per share of $15.00, or 200,000 restricted shares, in exchange for an amendment to extend the distributor agreement term to June 10, 2026. Assuming the distribution agreement has not been terminated by either party for cause, 50% of the shares are released on October 11, 2023 and the remaining 50% are released on October 11, 2024. The grant was accounted for as a stock-based sales incentive based on guidance in ASC 606 and is reflected as a reduction in the transaction price of revenue on the basis of the grant-date fair-value measure in accordance with the stock compensation guidance in ASC 718. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The domestic and foreign components of the Company’s income before income taxes are as follows: Year Ended December 31, 2022 2021 2020 Domestic $ 5,634 $ 15,085 $ 33,412 Foreign 5,207 9,144 10,188 Income before income taxes $ 10,841 $ 24,229 $ 43,600 The income tax expense for the years ended December 31, 2022, 2021, and 2020 consist of the following: Year Ended December 31, 2022 2021 2020 Current Federal $ 3,654 $ 3,343 $ 1,871 State and local 1,477 1,076 886 Foreign 965 2,435 1,874 6,096 6,854 4,631 Deferred Federal $ (2,940) $ (304) $ 4,884 State and local (839) (29) 1,403 Foreign 710 (1,284) (5) (3,069) (1,617) 6,282 Total $ 3,027 $ 5,237 $ 10,913 The reconciliation of the U.S. federal statutory rate to the Company’s effective rate is as follows: 2022 2021 2020 Income tax benefit using U.S. federal statutory rate 21.0 % 21.0 % 21.0 % State and local taxes. net of U.S. federal income tax benefit 4.7 % 3.6 % 4.7 % Global intangible low-taxed income — % 1.8 % 2.7 % Stock compensation (3.9 %) — % — % Officer's compensation limitation 4.4 % — % — % Tax attribute expiration — % — % 1.5 % Permanent differences 0.3 % 0.4 % (0.1 %) Foreign rate differential (2.9 %) (1.8 %) (0.4 %) Foreign derived intangible income (3.6 %) (1.9 %) (0.8 %) Valuation allowance 5.4 % (3.2 %) (1.2 %) Return to provision — % (0.1 %) 0.3 % Tax credits (0.6 %) (1.8 %) (2.7 %) IPO costs — % 2.1 % — % Other 3.1 % 1.5 % — % Provision for income taxes 27.9 % 21.6 % 25.0 % Deferred tax assets and liabilities at December 31, 2022 and 2021, consist of the following: 2022 2021 Deferred Tax Assets: Inventory reserves $ 878 $ 562 Reserves and accruals 1,330 868 Stock based compensation 3,728 2,632 Net operating loss carryforwards 4,834 5,454 Charitable contributions carryforward — 356 Lease liability 673 — Subtotal 11,443 9,872 Valuation allowance (4,586) (4,267) Total deferred tax assets 6,857 5,605 Deferred Tax Liabilities: Prepaid insurance (397) (615) Intangibles (1,464) (3,453) Right-of-use assets (646) — Fixed assets (84) (183) Other—Net (10) (89) Total deferred tax liabilities (2,601) (4,340) Net deferred tax assets (liability) $ 4,256 $ 1,265 A valuation allowance of $4,586 and $4,267 was recorded against the non-US deferred tax asset balance as of December 31, 2022 and 2021, respectively. As of each reporting date, management considers new evidence, both positive and negative, that could affect its view of the future realization of deferred tax assets. As of December 31, 2022 and 2021, management determined that there is sufficient positive evidence to conclude that it is more likely than not that the US deferred taxes are realizable. A valuation allowance has been established against the net operating loss carryforwards which has been generated by our foreign jurisdictions. As of December 31, 2022 and 2021, the Company had no US state and federal net operating loss carryforwards. As of December 31, 2022 and 2021, the Company had net operating loss carryforwards related to foreign operations of $22,987 and $24,920, respectively. These net operating loss carryforwards have various lives ranging from 10 years to indefinite carryforward periods. A reconciliation of the beginning and ending amount of income tax uncertainties is as follows; 2022 Beginning balance as of January 1, 2022 $ — Additions based on tax positions related to prior years 144 Additions based on tax positions related to current year — Ending balance as of December 31, 2022 $ 144 As of December 31, 2022 and 2021, there were $144 and $0 liabilities for income tax uncertainties recorded in the Company’s consolidated balance sheets. The Company recognized interest and penalties related to income tax uncertainties of $50 and $0 in its consolidated balance sheets or consolidated statements of operations for years ended December 31, 2022 and 2021, respectively. The Company is subject to income tax examinations by the IRS and various state and local jurisdictions for the open tax years between December 31, 2019 and December 31, 2022. As of December 31, 2022 and 2021, income taxes on undistributed earnings of the Company’s foreign subsidiaries have not been provided for as the Company plans to indefinitely reinvest these amounts. The cumulative undistributed foreign earnings were not material as of December 31, 2022 and 2021. During the second quarter of 2021, the Finance Act 2021 (the Finance Act) was enacted in the United Kingdom. The Finance Act increases the corporate income tax rate from 19% to 25% effective April 1, 2023 and enhances the first-year capital allowance on qualifying new plant and machinery assets effective April 1, 2021. The effects on the Company’s existing deferred tax balances have been recorded and is offset by the valuation allowance maintained against the Company’s U.K. net deferred tax assets. |
Earnings Per Share
Earnings Per Share | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share Basic and diluted earnings per share is calculated as follows: Year Ended December 31, 2022 2021 2020 Numerator: Net income attributable to The Vita Coco Company, Inc. $ 7,814 $ 19,015 $ 32,660 Denominator: Weighted-average number of common shares used in earnings per share—basic 55,732,619 53,689,910 58,501,170 Effect of conversion of stock options and RSU's 391,042 496,211 109,655 Weighted-average number of common shares used in earnings per share—diluted 56,123,661 54,186,121 58,610,825 Earnings per share—basic $ 0.14 $ 0.35 $ 0.56 Earnings per share—diluted $ 0.14 $ 0.35 $ 0.56 The vested service warrants are exercisable for little consideration and all necessary conditions have been satisfied as of December 31, 2021. Accordingly, the calculation of weighted average common shares outstanding includes vested service warrants, exercisable for a value of $0.000022. All exit warrants expired as of December 31, 2021. Before expiration, for the year ended December 31, 2021, the exit warrants, which expired upon a liquidity event and only vest when proceeds from a liquidity event provide an annual internal rate of return of less than 30%, were not considered in the basic and diluted earnings per share, as the contingency of a liquidity event had not occurred. The following potentially dilutive securities, prior to the use of the treasury stock method, have been excluded from the computation of diluted weighted-average number of common shares outstanding, as they would be anti-dilutive: December 31, 2022 2021 2020 Options to purchase common stock 1,880,904 1,288,350 3,719,625 |
Employee Benefit Plan
Employee Benefit Plan | 12 Months Ended |
Dec. 31, 2022 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plan | Employee Benefit PlanEmployees of the Company may participate in a defined contribution plan which qualifies under Section 401(k) of the Internal Revenue Code. Participating employees may contribute into a traditional plan with pretax salary or into a Roth plan with after tax salary up to statutory limits. The Company matches contributions up to 3% of each employee’s earnings, which vest over 2 years. Matching contributions were $592, $475 and $372 for the years ended December 31, 2022, 2021 and 2020, respectively. |
Segment Reporting
Segment Reporting | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Segment Reporting | Segment Reporting The Company has two operating and reportable segments: • Americas—The Americas segment is comprised primarily of US and Canada and derives its revenues from the marketing and distribution of various coconut water and non-coconut water products (e.g., oil and milk). The Company’s Guayusa leaf products ( Runa ), aluminum bottle canned water ( Ever & Ever ) and protein infused water ( PWR LIFT ) are marketed only in the Americas segment. • International—The International segment is comprised primarily of Europe, Middle East, Africa and Asia Pacific, which includes the Company’s procurement arm, and derives its revenues from the marketing and distribution of various coconut water and non-coconut water products. The Company’s CEO is the chief operating decision maker and evaluates segment performance primarily based on net sales and gross profit. All intercompany transactions between the segments have been eliminated. Information about the Company’s operations by operating segment as of and for the years ended December 31, 2022, 2021 and 2020 is as follows: December 31, 2022 Americas International Consolidated Net sales $ 373,622 $ 54,165 $ 427,787 Gross profit 95,492 7,869 103,361 Total segment assets 156,588 41,169 197,757 December 31, 2021 Americas International Consolidated Net sales $ 323,891 $ 55,622 $ 379,513 Gross profit 101,864 11,284 113,148 Total segment assets 141,973 55,511 197,484 December 31, 2020 Americas International Consolidated Net sales $ 262,899 $ 47,745 $ 310,644 Gross profit 90,256 14,602 104,858 Total segment assets 139,452 44,409 183,861 Year Ended December 31, Reconciliation 2022 2021 2020 Total gross profit $ 103,361 $ 113,148 $ 104,858 Less: Selling, general and administrative expenses 100,306 88,559 74,401 Change in fair value of contingent consideration — — (16,400) Income from operations 3,055 24,589 46,857 Less: Unrealized (gain) loss on derivative instruments (6,606) (2,093) 4,718 Foreign currency (gain) loss (1,387) 2,088 (1,848) Loss on extinguishment of debt — 132 — Interest income (51) (127) (404) Interest expense 258 360 791 Income before income taxes 10,841 24,229 43,600 Geographic Data: The following table provides information related to the Company’s net revenues by country, which is presented on the basis of the location that revenue from customers is recorded: Year Ended December 31, 2022 2021 2020 United States $ 352,731 $ 323,891 $ 262,899 All other countries (1) 75,056 55,622 47,745 Net sales $ 427,787 $ 379,513 $ 310,644 (1) No individual country is greater than 10% of total net sales for the years ended December 31, 2022, 2021 and 2020. The following table provides information related to the Company’s property and equipment, net by country: Year Ended December 31, 2022 2021 United States $ 683 $ 890 Ecuador 503 870 Singapore 1,288 536 All other countries (1) 105 177 Property and equipment, net $ 2,579 $ 2,473 (1) No individual country is greater than 10% of total property and equipment, net as of December 31, 2022 and 2021. |
Related-Party Transactions
Related-Party Transactions | 12 Months Ended |
Dec. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related-Party Transactions | Related-Party Transactions Management Fees —The Company is subject to an arrangement with one of its stockholders for as long as such stockholder holds at least 5% of the Company’s capital stock. Pursuant to the terms of the amended arrangement, the Company was required to make fixed annual management fee payments of $281. On October 20, 2021, in connection with the IPO discussed in Note 1, the Stockholder’s Agreement was revised and the new Investor Rights Agreement does not include a management fee to this stockholder. For the year ended December 31, 2021, the Company had amounts due in accounts payable of $227 for the portion of the year prior to the execution of the new Investor Rights Agreement. Director Nominee Agreements - On May 24, 2022, two members of the board of directors appointed as nominees under the Investor Rights Agreement by Verlinvest Beverages SA, a stockholder of the Company, entered into nominee agreements instructing the Company to pay all cash compensation earned in connection with their board of director services to Verlinvest Beverages SA. Based on the aforementioned nominee agreements, RSUs granted to these two directors will be held by them as nominees for Verlinvest Beverages SA and, upon vesting of the RSUs, the shares will be transferred to Verlinvest Beverages SA. The nominee agreements are primarily between the directors and Verlinvest Beverages SA. The Company is a party to this arrangement solely to agree to the manner in which it would satisfy the compensation obligations to these directors. As of December 31, 2022, there is only one active member of the board of directors that is subject to this nominee agreement. Loan to Employee —On September 18, 2019 the Company extended a five year promissory note of $17,700 to its newly appointed President, in order for him to buy 1,739,010 shares of The Vita Coco Company, Inc.’s common stock in conjunction with his employment agreement. The interest on the note accrued annually at a rate of 1.78% with principal balance due at maturity. The purchase of the Company's shares occurred simultaneously with the commencement of the loan, as a result no funds were actually disbursed by the Company. The purchased shares were pledged as collateral to the loan until full repayment of the principal balance. On May 18, 2020, the Company amended the interest rate on the note to 0.58%. On September 16, 2021, Martin Roper, the CEO of the Company, repaid the outstanding principal balance and accrued interest in full satisfaction of the promissory note. Distribution Agreement with Shareholder – On October 1, 2019 the Company entered into a distribution agreement with one of its stockholders, which currently extends through December 31, 2022. The distribution agreement grants the stockholder the right to sell, resell and distribute designated products supplied by the Company within a specified territory. The amount of revenue recognized related to this distribution agreement was $6,375, $6,247, and $5,294 for the years ended December 31, 2022, 2021 and 2020, respectively. The amounts due from the stockholder in Accounts Receivable, net were $753 and $600 as of December 31, 2022 and 2021, respectively. Amounts payable to the stockholder in Accounts payable were $38 and $71 as of December 31, 2022 and 2021 respectively. Related to this distribution arrangement, the Company and the stockholder have a service agreement where the Company shares in the compensation costs of the stockholder’s employee managing the China market. The Company recorded $234, $215 and $132 for the years ended December 31, 2022, 2021 and 2020, respectively, in selling, general, and administrative expense for this service agreement. |
Assets Held For Sale
Assets Held For Sale | 12 Months Ended |
Dec. 31, 2022 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Assets Held For Sale | Asset held for sale The asset group held for sale consists of a farm in Ecuador which was the source of Guayusa leaves for our Runa products. Since the Company is able to source Guayusa through alternative means to produce the Runa products, as of September 30, 2022, the Company committed to a plan for disposal through sale. The Company performed a fair value assessment on the asset group held for sale consisting of land, a production plant, equipment and inventory. The Company obtained a valuation of the assets and adjusted the carrying amount down to their fair value less costs to sell, which resulted in a $619 impairment loss recorded in selling, general and administrative expenses. The remaining carrying amount is listed below. These assets held for sale do not qualify for discontinued operations reporting. Asset held for sale Amount Land $ 503 |
Leases
Leases | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases | Leases In January 2016, the Company entered into an operating lease for office space in New York, New York, which was set to expire in January 2023. In June 2022, the Company extended its lease agreement for the New York office to April 30, 2025 and remeasured the lease liability and right-of-use asset as of June 30, 2022. The Company pays for its proportionate share of building operating costs such as maintenance, utilities, and insurance that are treated as variable costs and excluded from the measurement of the lease. The Company also maintains additional leases for office space and equipment in London and Singapore, which are operating leases. On March 31, 2022, the Company renewed the lease for the Singapore office, extending it through June 30, 2025, which is reflected in the lease term. As of December 31, 2022, the Company did not have any additional operating leases that have not yet commenced with future undiscounted lease payments. The components of lease cost, which are included within operating expenses in the accompanying consolidated statements of operations, are summarized in the following table (in thousands). Any variable lease costs are immaterial. Year Ended December 31, 2022 Operating lease cost $ 1,124 The following table summarizes supplemental balance sheet information for the Company’s operating leases: Line Item in Balance Sheet As of December 31, 2022 Noncurrent assets: Operating lease right-of-use assets Right-of-use assets $ 2,679 Current liabilities: Current portion of operating lease liabilities Accrued expenses $ 734 Noncurrent liabilities: Non-current portion of operating lease liabilities Other long-term Liabilities $ 2,052 The following summarizes the weighted average remaining lease term and weighted average discount rate related to the Company’s right-of-use assets and lease liabilities recorded on the balance sheet as of December 31, 2022 : As of December 31, 2022 Weighted-average remaining lease terms 2.4 years Weighted average discount rate 1.5 % The following table summarizes supplemental cash flow information for the Company’s operating leases: As of December 31, 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 1,197 The following table presents the maturity of the Company’s operating lease liabilities as of December 31, 2022: Year ending December 31, Maturity of Lease Payments 2023 $ 1,218 2024 1,218 2025 437 2026 — Thereafter — Total lease payments $ 2,873 Less: imputed interest (87) Total lease liabilities $ 2,786 The aggregate minimum commitments for renting the office spaces under non-cancellable operating leases as of December 31, 2021 are summarized in the following table. This table was populated in accordance with the prior guidance under ASC 840, Leases . Years Ending December 31, Minimum Commitment 2022 $ 1,085 2023 226 2024 154 2025 51 2026 — Thereafter — $ 1,516 |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent EventsOn March 7, 2023, the Company announced that the board of directors of the Company approved the appointment of Corey Baker as the Company’s Chief Financial Officer. Mr. Baker joins the Company as Executive Vice President of Finance, and he will succeed to the position of Chief Financial Officer and assume the designation of Principal Financial Officer immediately following the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 with the SEC. Mr. Baker will succeed Rowena Ricalde, who has served as the Company’s Interim Chief Financial Officer since September 2022. Ms. Ricalde will be appointed Chief Accounting Officer and continue as the Principal Accounting Officer. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). |
Principles of Consolidation | Principles of ConsolidationThe consolidated financial statements include all the accounts of the wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation; the noncontrolling interest in consolidated subsidiaries presented in the accompanying consolidated financial statements represents the portion of AME stockholders’ equity, which is not directly owned by the Company. |
Use of Estimates | Use of Estimates Preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management considers many factors in selecting appropriate financial accounting policies and controls in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgement in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the consolidated financial statements relate to share-based compensation, assessing long-lived assets for impairment, estimating the net realizable value of inventories, the determination of accounts receivables reserve, assessing goodwill for impairment, the determination of the value of trade promotions and assessing the realizability of deferred income taxes. Actual results could differ from those estimates. |
Revenue Recognition, Cost of Goods Sold, and Shipping and Handling Costs | Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers ("ASC 606"). ASC 606 defines a five-step model that requires entities exercise judgment when considering the terms of contract(s), which include (1) identifying the contract or agreement with a customer, (2) identifying the performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. Revenue is recognized when control of the promised good is transferred to the customer in an amount that reflects the consideration to which the Company is expected to be entitled to receive in exchange for those products. Each contract includes a single performance obligation to transfer control of the product to the customer. For the Company’s various products in the Vita Coco Coconut Water and Other product categories (refer to Note 3, Revenue Recognition ), control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue. The transaction price recognized reflects the consideration the Company expects to receive in exchange for the sale of the product. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that would meet the criteria for a distinct good or service that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent fulfillment costs, which are included in cost of goods sold, rather than revenue. Additionally, the Company determined the production and distribution of Private Label products represents a distinct performance obligation. Since there is no alternative use for these products and the Company has the right to payment for performance completed to date, the Company recognizes the revenue for the production of these Private Label products over time as the production for open purchase orders is completed, which may be prior to any shipment. The resulting contract assets are recorded in prepaid expenses and other current assets. The Company provides trade promotions to its customers. These discounts do not meet the criteria for a distinct good or service and therefore, the Company reduces revenue for the discounts associated with meeting this obligation based on the expected value method. These consolidated financial statements include trade promotion accruals. Trade promotion accruals are made for invoices that have not yet been received as of year-end and are recorded as a reduction of sales. This promotion accrual is a management estimate based upon the known price of retail promotions and estimates of the sales volume during the promotion period. Cost of Goods Sold Costs of goods sold includes the costs of the products sold to customers, inbound and outbound shipping and handling costs, freight and duties, shipping and packaging supplies, and warehouse fulfillment costs incurred in operating and staffing warehouses. Shipping and Handling Costs |
Advertising Expenses | Advertising ExpensesAdvertising expenses are charged to expense in the period they are incurred and are recorded in selling, general and administrative expenses. |
Research and Development | Research and DevelopmentResearch and development costs are charged to expense in the period incurred and are recorded in selling, general and administrative expenses. |
Stock-Based Compensation | Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation — Stock Compensation ("ASC 718") for awards issued under the 2014 Stock Option and Restricted Stock Plan and the 2021 Stock Incentive Award Plan. The Company measures all awards based on their fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period of each stock award grant, which is generally the vesting period of the respective award by using the accelerated attribution method. The Company applies an estimated forfeiture rate derived from historical employee termination behavior. If the actual forfeitures differ from those estimated by management, adjustment to compensation expense may be required in future periods. The Company issues stock-based awards with service-based and performance-based and market-based vesting conditions. The Company recognizes expense for performance-based awards when it becomes probable that such awards will be earned over a requisite service period. The Company defers the recognition of compensation expense for the stock awards that vest upon qualifying liquidity events until the qualifying events are probable of occurrence. Stock awards are equity-classified, as they do not contain a cash settlement option or other features requiring them to be liability-classified. The Company uses the Black-Scholes option-pricing model to determine the fair value of stock awards with service-based vesting conditions and performance-based vesting conditions. For stock awards with performance-based and market-based vesting conditions, the Company uses the Barrier option valuation model to determine the fair value. |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC 740, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for differences between the consolidated financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future. Such deferred income tax assets and liabilities computations are based on enacted tax laws and rates applicable to periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred income tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax positions are included in income tax expense in the consolidated statement of operations and comprehensive income and accrued expenses in the consolidated balance sheets. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. |
Net Income per Common Share | Net Income per Common Share In accordance with ASC Topic 260 Earnings Per Share ("ASC 260"), net income per common share, on a basic and diluted basis, is presented for all periods, calculated using the treasury stock method. Basic net income per share is computed by dividing net income by the weighted average number of common shares and service warrants outstanding during each period. Diluted net income per share is computed by dividing net income by the weighted average number of common and dilutive common equivalent shares outstanding. The calculation of common equivalent shares assumes the exercise of dilutive in-the-money stock options, net of assumed treasury share repurchases at average market prices, as applicable. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents include cash on hand and money market instruments with maturities of three months or less. |
Accounts Receivable | Accounts Receivable Accounts receivable are reported net of an allowance for doubtful accounts. In determining such an allowance, the Company considers historical losses and existing economic conditions, as well as the credit quality of each customer. Accounts receivable are charged off when the Company deems amounts to be uncollectible. |
Inventory | Inventory Inventory represents raw materials, finished goods, packaging, and inbound shipping and handling and is reported at the lower of cost or net realizable value being determined using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company reserves for finished goods that are close to the date of expiration. |
Deferred Offering Costs | Deferred Offering CostsThe Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings as deferred offering costs until such financings are consummated. After consummation of an equity financing, these costs are recorded in stockholders’ equity as a reduction of additional paid-in capital generated as a result of the offering. If an in-process equity financing is abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the consolidated statements of operations. As a result of the completion of the IPO on October 25, 2021 as described in Note 1, deferred offering costs recorded during the period were netted against the proceeds of the offering and reflected as a component of additional paid-in-capital in the quarter ended December 31, 2021. |
Property and Equipment | Property and Equipment Property and equipment are stated at cost and are depreciated over the estimated useful lives of the related assets or in the case of leasehold improvements, the lease term if shorter, using the straight-line method of depreciation. Repairs and maintenance are charged to expense as incurred. The estimated useful lives of the Company’s property and equipment are as follows: • Equipment and computer software and hardware – 3-7 years • Leasehold improvements – The lesser of the life of the asset or the term of the lease • Vehicles – 5 years • Furniture and fixtures – 3-5 years |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets The Company evaluates the recoverability of its long-lived assets, principally intangibles and property and equipment, by comparing asset group’s carrying value to the expected undiscounted future cash flows to be generated from such assets when events or circumstances indicate that an impairment may have occurred. If the estimated undiscounted future cash flows are less than the carrying amount, an impairment loss is recorded based upon the difference between the carrying amount and the fair value of the asset. |
Acquisitions | Acquisitions The Company evaluates each of its acquisitions under the accounting framework in Accounting Standards Codification Topic 805, Business Combinations ("ASC 805"). ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired, the liabilities assumed and any non-controlling interest in the acquired entity, and recognize and measure goodwill or a gain from the purchase. The acquiree’s results are included in the consolidated financial statements from the date of the acquisition. The Company allocated the purchase price, including the fair value of any non-cash and contingent consideration, to the identifiable assets and liabilities of the relevant acquired business at their acquisition date fair values. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill. Contingent consideration payable in cash or a fixed dollar amount settleable in a variable number of shares is classified as a liability and recorded at fair value, with changes in fair value recorded as a component of operating expenses in the accompanying consolidated statements of operations. Transaction costs associated with business combinations are expensed as incurred and are included in selling, general and administrative expense in the consolidated statements of operations. The Company performs valuations of assets acquired, liabilities assumed, and contingent consideration and allocates the purchase price to its respective assets and liabilities. Determining the fair value of assets acquired, liabilities assumed, and contingent consideration requires the use of significant judgment and estimates including the selection of valuation methodologies, estimates of future revenue, costs and cash flows, discount rates, the probability of the achievement of specified milestones, and selection of comparable companies. The Company engages the assistance of |
Intangible assets and Goodwill | Intangible assets Intangible assets consist primarily of acquired trade names and distributor relationships. The Company determines the appropriate useful life of the intangible assets by performing an analysis of expected cash flows of the acquired assets. Intangible assets are amortized over their estimated useful lives of ten years, using the straight-line method, which approximates the pattern in which the economic benefits are consumed. The Company’s intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable, or a triggering event. When a triggering event is identified, a test of recoverability is performed by estimating the undiscounted future cash flows associated with such assets and comparing them to the carrying value of the asset. When the recoverability test fails, the Company measures the impairment loss based on the fair value of the assets compared to the carrying amount of the asset. The fair value of the trade names is determined through an income approach using the relief from royalty method. The fair value of the distributor relationships is determined through an income approach using the excess earnings method. Goodwill Goodwill represents the excess of the purchase price paid in excess of the fair value of net identifiable tangible and intangible assets acquired in a business combination and is measured in accordance with the provisions of ASC 350, Intangibles – Goodwill and Other ("ASC 350"). Goodwill is not amortized; instead goodwill is tested for impairment on an annual basis on December 31, or more frequently if the Company believes indicators of impairment exist. The Company has determined that there are three reporting units for purposes of testing goodwill for impairment: (i) the Americas reporting unit, (ii) the Europe reporting unit, and (iii) the Asia reporting unit. All of the Company’s goodwill is allocated to the Americas reporting unit. The Company first assesses qualitative factors to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. In performing the qualitative assessment, the Company reviews factors both specific to the reporting units and to the Company as a whole, such as financial performance, macroeconomic conditions, industry and market considerations, and the fair value of each reporting unit at the last valuation date. If the Company elects this option and believes, as a result of the qualitative assessment, that it is more likely than not that the carrying value of each of the reporting units exceeds their fair value, the quantitative impairment test is required; otherwise, no further testing is required. |
Supplier Advances | Supplier Advances The Company issues advances to certain manufacturers with interest at rates between 0% and 4% with terms extending to February 2028 . |
Foreign Currency | Foreign Currency The Company’s reporting currency is the U.S. dollar. The Company maintains the financial statements of each entity within the group in its local currency, which is also the entity’s functional currency. Gains and losses on transactions denominated in currencies other than the functional currency are included in determining net income for the period. All assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenue and expenses are translated at the average exchange rate applicable during the period. Translation gains and losses are included as a component of accumulated other comprehensive income in stockholders’ equity. Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included as a component of other income (expense) in the accompanying consolidated statements of operations when incurred. |
Derivative Instruments | Derivative InstrumentsThe Company periodically enters into forward foreign currency exchange contracts to hedge its foreign currency exposure. The fair value of these contracts is recorded in the consolidated balance sheets with a corresponding adjustment to the consolidated statements of operations for the change in fair value of the derivative instruments, as the contracts have not been designated as a hedge instrument. |
Segment Information | Segment Information The Company operates as two operating and reportable segments: (i) Americas segment, which is comprised of the Company’s operations in the Americas region, primarily in the U.S. and Canada, and (ii) International segment, which is comprised of the Company’s operations primarily in Europe, Middle East, Africa and the Asia Pacific regions. The Company’s Chief Executive Officer, as the chief operating decision maker (CODM), manages and allocates resources between the Americas and International segments. Consistent with this decision-making process, the CEO uses financial information disaggregated between the Americas and International segment for purposes of evaluating performance, forecasting future period financial results, allocating resources and setting incentive targets. The CEO evaluates segment business performance based primarily on net sales and gross profit. |
Concentration of Credit Risk | Concentration of Credit Risk The Company’s cash and accounts receivable are subject to concentrations of credit risk. The Company’s cash balances are primarily on deposit with banks in the U.S. which are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $250. At times, such cash may be in excess of the FDIC insurance limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions and any excess cash above a certain minimum balance could be invested in overnight money market treasury deposits in widely diversified accounts. |
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements | Recently Adopted Accounting Pronouncements In August 2018, the Financial Accounting Standards Board ("FASB") issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40). The update is associated with customer’s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. The standard aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amendments in this update require that a customer in a hosting arrangement that is a service contract follow the guidance in Subtopic 350-40 to determine which implementation costs should be capitalized as an asset and which costs should be expensed and states that any capitalized implementation costs should be expensed over the term of the hosting arrangement. The guidance is effective for the Company for fiscal years beginning after December 15, 2020, and interim periods within annual periods beginning after December 15, 2021. The Company adopted the guidance in this amendment using a prospective approach effective January 1, 2021 for the fiscal year ended December 31, 2021. The adoption of ASU 2018-15 did not have a material impact on the consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), (“ASU 2019-12”) that simplify the accounting for income taxes by removing certain exceptions for recognizing deferred taxes for investments, performing intra-period allocation and calculating incomes taxes in interim periods. ASU 2019-12 also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of consolidated group. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements. In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance , which requires disclosure about certain government assistance they receive. ASU 2021-10 is effective for all entities for annual periods beginning after December 15, 2021. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This ASU should be applied prospectively to acquisitions occurring on or after the effective date of December 15, 2022, and early adoption is permitted. The Company adopted this standard for all prospective acquisitions after the effective date. In February 2016, the FASB issued ASC 842 , ASU 2016-02 , Leases (Topic 842), which was amended by subsequent Accounting Standard Updates ("ASUs"), to enhance the comparability and usefulness of financial reporting around leasing activity. The new standard supersedes the existing authoritative literature for lease accounting under ASC 840 , with a focus on applying a “right-of-use model.” The guidance for leases under ASC 842 results in a right-of-use asset (“ROU asset”) and lease liability being reported on the balance sheet for leases with a lease term greater than twelve months. In June 2020, the FASB issued ASU 2020-05 , Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842): Effective Dates for certain entities, which deferred the effective date of ASU 2016-02 for certain entities. ASC 842 is effective for the Company, as an Emerging Growth Company (“EGC”), for annual reporting periods beginning after December 15, 2021 and for interim periods beginning after December 15, 2022. The Company adopted the standard on January 1, 2022 using the alternative modified retrospective transition approach in accordance with ASU 2018-11 , Leases (Topic 842): Targeted Improvements, where the adoption date represents the initial date of application. As part of its adoption, the Company elected to apply the package of practical expedients requiring no reassessment of whether any expired or existing contracts are or contain leases, the lease classification of any expired or existing leases, or the capitalization of initial direct costs for any existing leases. Additionally, the Company elected the practical expedient that permits the exclusion of leases considered to be short-term. Under the alternative modified retrospective transition approach, the reported results for 2022 reflect the application of ASC 842 guidance, whereas comparative periods and the respective disclosures prior to the adoption of ASC 842 are presented using the legacy guidance of ASC 840 . As a result of adopting the new standard, the Company recognized right-of-use assets and lease liabilities of $1,866 and $2,097, respectively, on the Company’s consolidated balance sheet Recently Issued Accounting Pronouncements As a company with less than $1.07 billion of revenue during the last fiscal year, the Company qualifies as an “emerging growth company”, as defined in the Jumpstart Our Business Startups Act. This classification allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use the adoption dates applicable to private companies. As a result, the Company’s financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective date for new or revised accounting standards that are applicable to public companies. In June 2016, the FASB issued ASU 2016-13 Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods with those fiscal years, for nonpublic entities. Early adoption is permitted. This standard will be effective for the Company in the first quarter of its fiscal year ending December 31, 2023. The Company is assessing the impact of adoption on the consolidated financial statements, but does not expect the adoption of this standard to have a material impact on the Company's consolidated financial statements. |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Summary of Disaggregation of Revenue | The following table disaggregates net revenue by product type and reportable segment: December 31, 2022 Americas International Consolidated Vita Coco Coconut Water $ 275,964 $ 38,570 $ 314,534 Private Label 88,173 12,855 101,029 Other 9,485 2,740 12,224 Total $ 373,622 $ 54,165 $ 427,787 December 31, 2021 Americas International Consolidated Vita Coco Coconut Water $ 231,858 $ 34,639 $ 266,497 Private Label 80,639 14,007 94,646 Other 11,394 6,976 18,370 Total $ 323,891 $ 55,622 $ 379,513 December 31, 2020 Americas International Consolidated Vita Coco Coconut Water $ 164,786 $ 27,167 $ 191,953 Private Label 83,449 12,596 96,045 Other 14,664 7,982 22,646 Total $ 262,899 $ 47,745 $ 310,644 |
Accounts Receivable, Net (Table
Accounts Receivable, Net (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Receivables [Abstract] | |
Changes in Allowance for Doubtful Accounts | Changes in the allowance for doubtful accounts for the periods presented were as follows: Balance at January 1, 2021 $ 1,211 Provision charged to operating results 76 Account write-offs and other deductions, net of recoveries 14 Balance as of December 31, 2021 $ 1,301 Provision charged to operating results 2,641 Account write-offs and other deductions, net of recoveries (1,044) Balance as of December 31, 2022 $ 2,898 |
Inventory (Tables)
Inventory (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Inventory Disclosure [Abstract] | |
Summary of Inventory | Inventory consists of the following: December 31, 2022 2021 Raw materials and packaging $ 5,771 $ 4,868 Finished goods 78,344 70,492 Inventory $ 84,115 $ 75,360 |
Prepaid Expenses and Other Cu_2
Prepaid Expenses and Other Current Assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Schedule of Prepaid Expenses and Other Current Assets | Prepaid expenses and other current assets consist of the following: December 31, 2022 2021 Tax receivables $ 527 $ 2,946 Contract assets 10,337 2,627 VAT receivables 1,054 1,436 Supplier prepaid 4,018 6,182 Prepaid insurance 1,701 2,530 Other prepaid expenses 2,254 2,614 Other receivables 2,290 2,383 $ 22,181 $ 20,718 |
Property and Equipment, Net (Ta
Property and Equipment, Net (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | Property and equipment, net consist of the following: December 31, 2022 2021 Equipment and computer software and hardware $ 5,137 $ 4,604 Leasehold improvement 339 503 Vehicles 784 820 Land and improvements — 506 Furniture and fixtures 401 321 Total Property Plant & Equipment 6,661 6,754 Less accumulated depreciation and amortization (4,585) (4,281) Property and equipment-net $ 2,076 $ 2,473 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Summary of Goodwill | Goodwill and Intangible Assets, net consist of the following: December 31, 2022 2021 Goodwill $ 7,791 $ 7,791 |
Summary of Finite-Lived Intangible Assets | December 31, 2022 December 31, 2021 Gross Carrying Accumulated Impairment Net Gross Carrying Accumulated Net Intangible assets, net Trade names $ 6,200 $ (2,807) $ (3,393) $ — $ 6,200 $ (2,187) $ 4,013 Distributor relationships 6,000 (2,717) (3,283) $ — 6,000 (2,117) 3,883 Other 38 — (38) $ — 38 — 38 Total Intangible assets subject to amortization & impairment $ 12,238 $ (5,524) $ (6,714) $ — 12,238 $ (4,304) $ 7,934 |
Accrued Expenses (Tables)
Accrued Expenses (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Payables and Accruals [Abstract] | |
Schedule of Accrued Liabilities | Accrued expenses consist of the following: December 31, 2022 2021 Accrued promotions and marketing $ 18,624 $ 19,455 Payroll and benefits related expenses 3,814 10,258 Shipping and handling costs 8,854 4,175 Accrued trade payable 1,613 1,647 Current operating lease liabilities 734 — VAT payable 1,599 2,276 Income tax payable 834 2,138 Accrued professional fees 350 628 Other accrued expenses 1,920 1,822 $ 38,342 $ 42,399 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Summary of Credit Facility and Notes Payable | The table below details the outstanding balances on the Company’s credit facility and notes payable as of December 31, 2022 and 2021: December 31, 2022 2021 2020 Credit facility $ — $ — Notes payable Vehicle loans 48 76 $ 48 $ 76 Current $ 23 $ 28 Non-current $ 25 $ 48 |
Summary of Maturities of Long-term Debt | Aggregate principal payments on the notes payable for the next five years are as follows: 2023 $ 22 2024 13 2025 10 2026 3 Total notes payable $ 48 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Concentration of Risk, by Risk Factor | The Company’s customers that accounted for 10% or more of total net sales and total accounts receivable were as follows: Net sales Accounts receivable Year Ended December 31, December 31, 2022 2021 2020 2022 2021 Customer A 30 % 30 % 35 % 16 % 18 % Customer B 24 % 23 % 19 % 23 % 19 % Year Ended December 31, 2022 2021 Supplier A 17 % 21 % Supplier B 13 % 13 % |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Summary of Notional Amount and Fair Value of All Outstanding Derivative Instruments | The notional amount and fair value of all outstanding derivative instruments in the consolidated balance sheets consist of the following at: December 31, 2022 Derivatives not designated as hedging instruments under ASC 815-20 Notional Fair Value Balance Sheet Location Assets Foreign currency exchange contracts Receive USD/pay GBP $ 23,702 $ 1,104 Derivative assets Receive BRL/sell USD 46,301 2,314 Derivative assets Receive USD/pay CAD $ 4,819 $ 188 Derivative assets Liabilities Foreign currency exchange contracts Receive USD/pay EUR $ 604 $ (7) Derivative liabilities Receive THB/sell USD 21,990 (64) Derivative liabilities December 31, 2021 Derivatives not designated as hedging instruments under ASC 815-20 Notional Fair Value Balance Sheet Location Assets Foreign currency exchange contracts Receive USD/pay GBP $ 22,323 $ 125 Derivative assets Receive MYR/sell USD $ 392 $ 1 Derivative assets Liabilities Foreign currency exchange contracts Receive BRL/sell USD $ 43,174 $ (2,389) Derivative liabilities Receive USD/pay CAD 4,731 (57) Derivative liabilities Receive THB/sell USD 18,488 (751) Derivative liabilities |
Summary of Realized and Unrealized Gains and Losses of the Derivative Instruments | The amount of realized and unrealized gains and losses and consolidated statements of operations and comprehensive income location of the derivative instruments as of December 31, 2022 and 2021 are as follows: 2022 2021 2020 Unrealized gain (loss) on derivative instruments $ 6,606 $ 2,093 $ (4,718) Location Unrealized gain on derivative instruments Unrealized gain on derivative instruments Unrealized (loss) on derivative instruments Foreign currency gain (loss) $ 2,682 $ (5,679) $ 6,765 Location Foreign currency gain Foreign currency (loss) Foreign currency gain |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis | The Company’s fair value hierarchy for those assets (liabilities) measured at fair value on a recurring basis at December 31, 2022 and 2021, is as follows: Level 1 Level 2 Level 3 Total 2022 $ — $ 3,535 $ — $ 3,535 2021 $ — $ (3,071) $ — $ (3,071) |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |
Summary of Stock Option Activity | The following table summarizes the service-based stock option activity during the year ended December 31, 2022: Number of Weighted- Weighted- Aggregate (per option) (in years) (in thousands) Outstanding—December 31, 2021 4,117,671 $ 10.34 Granted 128,940 15.36 Exercised 370,940 8.36 Forfeited 161,697 11.27 Outstanding—December 31, 2022 3,713,974 $ 11.00 7.0 $ 10,062 Exercisable—December 31, 2022 2,129,042 $ 10.29 6.7 $ 7,522 The following table summarizes the stock option activity during the year ended December 31, 2022: Number of Weighted- Weighted- Aggregate (per option) (in years) (in thousands) Outstanding—December 31, 2021 778,960 $ 10.33 Granted 38,675 10.18 Exercised — — Forfeited 9,100 10.18 Outstanding—December 31, 2022 808,535 $ 10.32 6.9 $ 2,658 |
Summary of Weighted Average Assumptions Used in The Black-Scholes Option-pricing Model | The weighted average assumptions used in the Black-Scholes option-pricing model were as follows: 2022 2021 Weighted average expected term 7.00 years 6.3 years Weighted average expected volatility 39 % 39 % Weighted average risk-free interest rate 2.86 % 1.19 % Weighted average expected dividend yield 0 % 0 % Weighted average expected term 2.44 years Weighted average expected volatility 40 % Weighted average risk-free interest rate 0.16 % Weighted average expected dividend yield 0 % |
Summary of Restricted Stock and Restricted Stock Unit Activity | The following table summarizes the restricted stock and RSU activity for the year ended December 31, 2022: Number of Restricted Stock or RSU Awards Weighted Average Grant Date Fair Value Non-vested - December 31, 2021 454,881 $ 15.00 Granted 342,637 $ 12.97 Vested 89,728 $ 15.00 Forfeited/Cancelled 41,613 $ 13.12 Non-vested - December 31, 2022 666,177 $ 14.08 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income before Income Tax, Domestic and Foreign | The domestic and foreign components of the Company’s income before income taxes are as follows: Year Ended December 31, 2022 2021 2020 Domestic $ 5,634 $ 15,085 $ 33,412 Foreign 5,207 9,144 10,188 Income before income taxes $ 10,841 $ 24,229 $ 43,600 |
Schedule of Components of Income Tax Expense | The income tax expense for the years ended December 31, 2022, 2021, and 2020 consist of the following: Year Ended December 31, 2022 2021 2020 Current Federal $ 3,654 $ 3,343 $ 1,871 State and local 1,477 1,076 886 Foreign 965 2,435 1,874 6,096 6,854 4,631 Deferred Federal $ (2,940) $ (304) $ 4,884 State and local (839) (29) 1,403 Foreign 710 (1,284) (5) (3,069) (1,617) 6,282 Total $ 3,027 $ 5,237 $ 10,913 |
Schedule of Effective Income Tax Rate Reconciliation | The reconciliation of the U.S. federal statutory rate to the Company’s effective rate is as follows: 2022 2021 2020 Income tax benefit using U.S. federal statutory rate 21.0 % 21.0 % 21.0 % State and local taxes. net of U.S. federal income tax benefit 4.7 % 3.6 % 4.7 % Global intangible low-taxed income — % 1.8 % 2.7 % Stock compensation (3.9 %) — % — % Officer's compensation limitation 4.4 % — % — % Tax attribute expiration — % — % 1.5 % Permanent differences 0.3 % 0.4 % (0.1 %) Foreign rate differential (2.9 %) (1.8 %) (0.4 %) Foreign derived intangible income (3.6 %) (1.9 %) (0.8 %) Valuation allowance 5.4 % (3.2 %) (1.2 %) Return to provision — % (0.1 %) 0.3 % Tax credits (0.6 %) (1.8 %) (2.7 %) IPO costs — % 2.1 % — % Other 3.1 % 1.5 % — % Provision for income taxes 27.9 % 21.6 % 25.0 % |
Schedule of Deferred Tax Assets and Liabilities | Deferred tax assets and liabilities at December 31, 2022 and 2021, consist of the following: 2022 2021 Deferred Tax Assets: Inventory reserves $ 878 $ 562 Reserves and accruals 1,330 868 Stock based compensation 3,728 2,632 Net operating loss carryforwards 4,834 5,454 Charitable contributions carryforward — 356 Lease liability 673 — Subtotal 11,443 9,872 Valuation allowance (4,586) (4,267) Total deferred tax assets 6,857 5,605 Deferred Tax Liabilities: Prepaid insurance (397) (615) Intangibles (1,464) (3,453) Right-of-use assets (646) — Fixed assets (84) (183) Other—Net (10) (89) Total deferred tax liabilities (2,601) (4,340) Net deferred tax assets (liability) $ 4,256 $ 1,265 |
Schedule of Unrecognized Tax Benefits Roll Forward | A reconciliation of the beginning and ending amount of income tax uncertainties is as follows; 2022 Beginning balance as of January 1, 2022 $ — Additions based on tax positions related to prior years 144 Additions based on tax positions related to current year — Ending balance as of December 31, 2022 $ 144 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Summary of Basic and diluted earnings per share | Basic and diluted earnings per share is calculated as follows: Year Ended December 31, 2022 2021 2020 Numerator: Net income attributable to The Vita Coco Company, Inc. $ 7,814 $ 19,015 $ 32,660 Denominator: Weighted-average number of common shares used in earnings per share—basic 55,732,619 53,689,910 58,501,170 Effect of conversion of stock options and RSU's 391,042 496,211 109,655 Weighted-average number of common shares used in earnings per share—diluted 56,123,661 54,186,121 58,610,825 Earnings per share—basic $ 0.14 $ 0.35 $ 0.56 Earnings per share—diluted $ 0.14 $ 0.35 $ 0.56 |
Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following potentially dilutive securities, prior to the use of the treasury stock method, have been excluded from the computation of diluted weighted-average number of common shares outstanding, as they would be anti-dilutive: December 31, 2022 2021 2020 Options to purchase common stock 1,880,904 1,288,350 3,719,625 |
Segment Reporting (Tables)
Segment Reporting (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Schedule of Segment Reporting Information by Segment | Information about the Company’s operations by operating segment as of and for the years ended December 31, 2022, 2021 and 2020 is as follows: December 31, 2022 Americas International Consolidated Net sales $ 373,622 $ 54,165 $ 427,787 Gross profit 95,492 7,869 103,361 Total segment assets 156,588 41,169 197,757 December 31, 2021 Americas International Consolidated Net sales $ 323,891 $ 55,622 $ 379,513 Gross profit 101,864 11,284 113,148 Total segment assets 141,973 55,511 197,484 December 31, 2020 Americas International Consolidated Net sales $ 262,899 $ 47,745 $ 310,644 Gross profit 90,256 14,602 104,858 Total segment assets 139,452 44,409 183,861 |
Reconciliation of Gross Profit to Income Loss Before Income Taxes | Year Ended December 31, Reconciliation 2022 2021 2020 Total gross profit $ 103,361 $ 113,148 $ 104,858 Less: Selling, general and administrative expenses 100,306 88,559 74,401 Change in fair value of contingent consideration — — (16,400) Income from operations 3,055 24,589 46,857 Less: Unrealized (gain) loss on derivative instruments (6,606) (2,093) 4,718 Foreign currency (gain) loss (1,387) 2,088 (1,848) Loss on extinguishment of debt — 132 — Interest income (51) (127) (404) Interest expense 258 360 791 Income before income taxes 10,841 24,229 43,600 |
Net Revenues by Country | The following table provides information related to the Company’s net revenues by country, which is presented on the basis of the location that revenue from customers is recorded: Year Ended December 31, 2022 2021 2020 United States $ 352,731 $ 323,891 $ 262,899 All other countries (1) 75,056 55,622 47,745 Net sales $ 427,787 $ 379,513 $ 310,644 (1) No individual country is greater than 10% of total net sales for the years ended December 31, 2022, 2021 and 2020. |
Property and Equipment, Net By Country | The following table provides information related to the Company’s property and equipment, net by country: Year Ended December 31, 2022 2021 United States $ 683 $ 890 Ecuador 503 870 Singapore 1,288 536 All other countries (1) 105 177 Property and equipment, net $ 2,579 $ 2,473 (1) No individual country is greater than 10% of total property and equipment, net as of December 31, 2022 and 2021. |
Assets Held For Sale (Tables)
Assets Held For Sale (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Schedule of Assets Held For Sale | The remaining carrying amount is listed below. These assets held for sale do not qualify for discontinued operations reporting. Asset held for sale Amount Land $ 503 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Components of Lease Cost | The components of lease cost, which are included within operating expenses in the accompanying consolidated statements of operations, are summarized in the following table (in thousands). Any variable lease costs are immaterial. Year Ended December 31, 2022 Operating lease cost $ 1,124 The following table summarizes supplemental cash flow information for the Company’s operating leases: As of December 31, 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 1,197 |
Supplemental Balance Sheet Information for Operating Leases | The following table summarizes supplemental balance sheet information for the Company’s operating leases: Line Item in Balance Sheet As of December 31, 2022 Noncurrent assets: Operating lease right-of-use assets Right-of-use assets $ 2,679 Current liabilities: Current portion of operating lease liabilities Accrued expenses $ 734 Noncurrent liabilities: Non-current portion of operating lease liabilities Other long-term Liabilities $ 2,052 |
Summary of the Weighted Average Remaining Lease Term and Weighted Average Discount Rate | The following summarizes the weighted average remaining lease term and weighted average discount rate related to the Company’s right-of-use assets and lease liabilities recorded on the balance sheet as of December 31, 2022 : As of December 31, 2022 Weighted-average remaining lease terms 2.4 years Weighted average discount rate 1.5 % |
Schedule of Operating Lease Liability Maturity | The following table presents the maturity of the Company’s operating lease liabilities as of December 31, 2022: Year ending December 31, Maturity of Lease Payments 2023 $ 1,218 2024 1,218 2025 437 2026 — Thereafter — Total lease payments $ 2,873 Less: imputed interest (87) Total lease liabilities $ 2,786 |
Schedule of Future Minimum Rental Payments for Operating Leases | The aggregate minimum commitments for renting the office spaces under non-cancellable operating leases as of December 31, 2021 are summarized in the following table. This table was populated in accordance with the prior guidance under ASC 840, Leases . Years Ending December 31, Minimum Commitment 2022 $ 1,085 2023 226 2024 154 2025 51 2026 — Thereafter — $ 1,516 |
Nature of Business and Basis _2
Nature of Business and Basis of Presentation (Details) $ / shares in Units, $ in Thousands | 12 Months Ended | |||
Oct. 25, 2021 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) subsidiary $ / shares | Dec. 31, 2021 USD ($) $ / shares shares | Dec. 31, 2020 USD ($) | |
Subsidiaries Owned [Line Items] | ||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.01 | $ 0.01 | ||
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and offering costs | $ 0 | $ 30,356 | $ 0 | |
IPO | ||||
Subsidiaries Owned [Line Items] | ||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.01 | |||
Payments for underwriting expense | $ 2,000 | |||
Payments of stock issuance costs | $ 5,000 | |||
Common Stock | ||||
Subsidiaries Owned [Line Items] | ||||
Issuance of common shares (in shares) | shares | 2,500,000 | |||
Common Stock | IPO | ||||
Subsidiaries Owned [Line Items] | ||||
Issuance of common shares (in shares) | shares | 2,500,000 | |||
Shares issued, price per share (in dollars per share) | $ / shares | $ 15 | |||
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and offering costs | $ 30,000 | |||
Sale of stock, number of shares issued in transaction (in shares) | shares | 9,000,000 | |||
Subsidiaries | ||||
Subsidiaries Owned [Line Items] | ||||
Number of subsidiaries | subsidiary | 9 | |||
Subsidiaries | Asia | ||||
Subsidiaries Owned [Line Items] | ||||
Number of subsidiaries | subsidiary | 4 | |||
Subsidiaries | North America | ||||
Subsidiaries Owned [Line Items] | ||||
Number of subsidiaries | subsidiary | 1 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies - Shipping and Handling Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue from External Customer [Line Items] | |||
Cost of goods sold | $ 324,426 | $ 266,365 | $ 205,786 |
Shipping and Handling | |||
Revenue from External Customer [Line Items] | |||
Cost of goods sold | $ 13,387 | $ 9,331 | $ 7,353 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Advertising Expenses (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | |||
Advertising expenses | $ 14,404 | $ 13,755 | $ 12,862 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Research and Development (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | |||
Research and development expenses | $ 541 | $ 477 | $ 313 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Deferred Offering Costs (Details) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Accounting Policies [Abstract] | ||
Deferred offering costs | $ 0 | $ 0 |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies - Property and Equipment (Details) | 12 Months Ended |
Dec. 31, 2022 | |
Equipment and computer software and hardware | Minimum | |
Property, Plant and Equipment [Line Items] | |
Property and equipment, useful life | 3 years |
Equipment and computer software and hardware | Maximum | |
Property, Plant and Equipment [Line Items] | |
Property and equipment, useful life | 7 years |
Vehicles | |
Property, Plant and Equipment [Line Items] | |
Property and equipment, useful life | 5 years |
Furniture and fixtures | Minimum | |
Property, Plant and Equipment [Line Items] | |
Property and equipment, useful life | 3 years |
Furniture and fixtures | Maximum | |
Property, Plant and Equipment [Line Items] | |
Property and equipment, useful life | 5 years |
Summary of Significant Accoun_8
Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details) | 12 Months Ended | ||
Dec. 31, 2022 USD ($) reportingUnit | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | |
Accounting Policies [Abstract] | |||
Intangible asset estimated useful life | 10 years | ||
Number of reporting units | reportingUnit | 3 | ||
Impairment to goodwill | $ | $ 0 | $ 0 | $ 0 |
Summary of Significant Accoun_9
Summary of Significant Accounting Policies - Supplier Advances (Details) | Dec. 31, 2022 USD ($) |
Supplier Advances [Line Items] | |
Allowance for supplier advances | $ 0 |
Minimum | |
Supplier Advances [Line Items] | |
Supplier advances, interest rate | 0% |
Maximum | |
Supplier Advances [Line Items] | |
Supplier advances, interest rate | 4% |
Summary of Significant Accou_10
Summary of Significant Accounting Policies - Segment Information (Details) | 12 Months Ended |
Dec. 31, 2022 segment | |
Accounting Policies [Abstract] | |
Number of operating segments | 2 |
Number of reportable segments | 2 |
Summary of Significant Accou_11
Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) - Customer Concentration Risk - Two Customers | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Net Sales Revenue | |||
Product Information [Line Items] | |||
Concentration risk, percentage | 54% | 53% | 54% |
Accounts Receivable | |||
Product Information [Line Items] | |||
Concentration risk, percentage | 39% | 37% |
Summary of Significant Accou_12
Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements (Details) - USD ($) $ in Thousands | Jan. 01, 2022 | Dec. 31, 2022 | Dec. 31, 2021 |
Accounting Policies [Abstract] | |||
Right-of-use asset | $ 1,866 | $ 2,679 | $ 0 |
Total lease liabilities | 2,097 | $ 2,786 | |
Reclassification of deferred rent liability | $ 231 | ||
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] | Accrued expenses, Other long-term liabilities | Accrued expenses, Other long-term liabilities |
Revenue Recognition (Details)
Revenue Recognition (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | |||
Revenue | $ 427,787 | $ 379,513 | $ 310,644 |
Vita Coco Coconut Water | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 314,534 | 266,497 | 191,953 |
Private Label | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 101,029 | 94,646 | 96,045 |
Other | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 12,224 | 18,370 | 22,646 |
Operating Segments | Americas | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 373,622 | 323,891 | 262,899 |
Operating Segments | Americas | Vita Coco Coconut Water | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 275,964 | 231,858 | 164,786 |
Operating Segments | Americas | Private Label | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 88,173 | 80,639 | 83,449 |
Operating Segments | Americas | Other | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 9,485 | 11,394 | 14,664 |
Operating Segments | International | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 54,165 | 55,622 | 47,745 |
Operating Segments | International | Vita Coco Coconut Water | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 38,570 | 34,639 | 27,167 |
Operating Segments | International | Private Label | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 12,855 | 14,007 | 12,596 |
Operating Segments | International | Other | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | $ 2,740 | $ 6,976 | $ 7,982 |
Accounts Receivable, Net - Addi
Accounts Receivable, Net - Additional Information (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Receivables [Abstract] | |||
Accounts receivable, net | $ 43,350 | $ 47,195 | |
Allowance for credit loss | $ 2,898 | $ 1,301 | $ 1,211 |
Accounts Receivable, Net - Chan
Accounts Receivable, Net - Changes in Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | ||
Allowance for credit loss, beginning balance | $ 1,301 | $ 1,211 |
Provision charged to operating results | 2,641 | 76 |
Account write-offs and other deductions, net of recoveries | (1,044) | 14 |
Allowance for credit loss, ending balance | $ 2,898 | $ 1,301 |
Inventory (Details)
Inventory (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Inventory Disclosure [Abstract] | ||
Raw materials and packaging | $ 5,771 | $ 4,868 |
Finished goods | 78,344 | 70,492 |
Inventory | $ 84,115 | $ 75,360 |
Prepaid Expenses and Other Cu_3
Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
Tax receivables | $ 527 | $ 2,946 |
Contract assets | 10,337 | 2,627 |
VAT receivables | 1,054 | 1,436 |
Supplier prepaid | 4,018 | 6,182 |
Prepaid insurance | 1,701 | 2,530 |
Other prepaid expenses | 2,254 | 2,614 |
Other receivables | 2,290 | 2,383 |
Prepaid expense and other current assets | $ 22,181 | $ 20,718 |
Property and Equipment, Net (De
Property and Equipment, Net (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Property, Plant and Equipment [Line Items] | |||
Total Property Plant & Equipment | $ 6,661 | $ 6,754 | |
Less accumulated depreciation and amortization | (4,585) | (4,281) | |
Total current assets | 2,076 | 2,473 | |
Depreciation expense | 681 | 849 | $ 905 |
Equipment and computer software and hardware | |||
Property, Plant and Equipment [Line Items] | |||
Total Property Plant & Equipment | 5,137 | 4,604 | |
Leasehold improvement | |||
Property, Plant and Equipment [Line Items] | |||
Total Property Plant & Equipment | 339 | 503 | |
Vehicles | |||
Property, Plant and Equipment [Line Items] | |||
Total Property Plant & Equipment | 784 | 820 | |
Land and improvements | |||
Property, Plant and Equipment [Line Items] | |||
Total Property Plant & Equipment | 0 | 506 | |
Furniture and fixtures | |||
Property, Plant and Equipment [Line Items] | |||
Total Property Plant & Equipment | $ 401 | $ 321 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Summary of Goodwill (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Goodwill | $ 7,791 | $ 7,791 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Summary of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 12,238 | $ 12,238 |
Accumulated Amortization | (5,524) | (4,304) |
Impairment | (6,714) | |
Intangible assets, net | 0 | 7,934 |
Trade names | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 6,200 | 6,200 |
Accumulated Amortization | (2,807) | (2,187) |
Impairment | (3,393) | |
Intangible assets, net | 0 | 4,013 |
Distributor relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 6,000 | 6,000 |
Accumulated Amortization | (2,717) | (2,117) |
Impairment | (3,283) | |
Intangible assets, net | 0 | 3,883 |
Other | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 38 | 38 |
Accumulated Amortization | 0 | 0 |
Impairment | (38) | |
Intangible assets, net | $ 0 | $ 38 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Additional Information (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Impairment to goodwill | $ 0 | $ 0 | $ 0 |
Intangible assets acquired | 0 | 7,934,000 | |
Impairment of intangible assets | 6,714,000 | 0 | 0 |
Amortization expense | $ 1,220,000 | $ 1,220,000 | $ 1,220,000 |
Accrued Expenses (Details)
Accrued Expenses (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Payables and Accruals [Abstract] | ||
Accrued promotions and marketing | $ 18,624 | $ 19,455 |
Payroll and benefits related expenses | 3,814 | 10,258 |
Shipping and handling costs | 8,854 | 4,175 |
Accrued trade payable | 1,613 | 1,647 |
Current operating lease liabilities | 734 | 0 |
VAT payable | 1,599 | 2,276 |
Income tax payable | 834 | 2,138 |
Accrued professional fees | 350 | 628 |
Other accrued expenses | 1,920 | 1,822 |
Current liabilities: | $ 38,342 | $ 42,399 |
Debt - Summary of Credit Facili
Debt - Summary of Credit Facility and Notes Payable (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Schedule Of Line Of Credit Facilities And Notes Payable [Line Items] | ||
2020 Credit facility | $ 0 | $ 0 |
Notes Payable [Abstract] | ||
Notes payable | 48 | 76 |
Current | 23 | 28 |
Non-current | 25 | 48 |
2020 Credit facility | ||
Schedule Of Line Of Credit Facilities And Notes Payable [Line Items] | ||
2020 Credit facility | 0 | 0 |
Vehicle loans | ||
Notes Payable [Abstract] | ||
Notes payable | $ 48 | $ 76 |
Debt - Additional Information (
Debt - Additional Information (Details) - USD ($) | 1 Months Ended | 12 Months Ended | ||||||
Apr. 25, 2017 | Aug. 09, 2016 | Oct. 31, 2021 | May 31, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | May 31, 2021 | |
Debt Instrument [Line Items] | ||||||||
Line of credit facility, commitment fee amount | $ 51,000 | $ 39,000 | ||||||
Loss on extinguishment of debt | $ 0 | 132,000 | $ 0 | |||||
2016 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, term | 5 years | |||||||
2017 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, term | 5 years | |||||||
Notes Payable to Banks | 2016 Term Loan and 2017 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Interest expense | 141,000 | $ 188,000 | ||||||
Notes Payable to Banks | 2016 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, face amount | $ 10,000,000 | |||||||
Notes Payable to Banks | 2017 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, face amount | $ 15,000,000 | |||||||
Notes Payable to Banks | Minimum | 2016 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Percentage of increase in the initial loan amount determining principal payments | 2.50% | |||||||
Notes Payable to Banks | Minimum | 2017 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Percentage of increase in the initial loan amount determining principal payments | 2.50% | |||||||
Notes Payable to Banks | Maximum | 2016 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Percentage of increase in the initial loan amount determining principal payments | 5% | |||||||
Notes Payable to Banks | Maximum | 2017 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Percentage of increase in the initial loan amount determining principal payments | 5% | |||||||
Notes Payable to Banks | London Interbank Offered Rate (LIBOR) | 2016 Term Loan and 2017 Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, basis spread on variable rate | 1.50% | |||||||
Notes Payable, Other Payables | Vehicle loans | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, periodic principal payment | $ 2,000 | |||||||
Notes Payable, Other Payables | Minimum | Vehicle loans | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, interest rate, stated percentage | 4.56% | |||||||
Notes Payable, Other Payables | Maximum | Vehicle loans | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, interest rate, stated percentage | 5.68% | |||||||
2020 Credit facility | ||||||||
Debt Instrument [Line Items] | ||||||||
Line of credit facility, interest expense | $ 255,000 | 176,000 | ||||||
2020 Credit facility | Line of Credit | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, term | 5 years | |||||||
Line of credit facility, maximum borrowing capacity | $ 60,000,000 | |||||||
Long-term line of credit | 0 | 0 | ||||||
Line of credit facility, remaining borrowing capacity | $ 60,000,000 | $ 60,000,000 | ||||||
Line of credit facility, effective interest rate | 2.53% | 0.97% | ||||||
2020 Credit facility | Line of Credit | Minimum | ||||||||
Debt Instrument [Line Items] | ||||||||
Line of credit facility, unused capacity, commitment fee percentage | 0.05% | |||||||
2020 Credit facility | Line of Credit | Maximum | ||||||||
Debt Instrument [Line Items] | ||||||||
Line of credit facility, unused capacity, commitment fee percentage | 0.20% | |||||||
2020 Credit facility | Line of Credit | Fed Funds Effective Rate | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, basis spread on variable rate | 1.50% | |||||||
2020 Credit facility | Line of Credit | London Interbank Offered Rate (LIBOR) | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, basis spread on variable rate | 1.50% | |||||||
2020 Credit facility | Line of Credit | London Interbank Offered Rate (LIBOR) | Minimum | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, basis spread on variable rate | 1% | |||||||
2020 Credit facility | Line of Credit | London Interbank Offered Rate (LIBOR) | Maximum | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, basis spread on variable rate | 1.75% | |||||||
2021 Term Loan | Notes Payable to Banks | Maximum | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, face amount | $ 30,000,000 |
Debt - Summary of Maturities of
Debt - Summary of Maturities of Long-term Debt (Details) - Notes Payable, Other Payables $ in Thousands | Dec. 31, 2022 USD ($) |
Debt Instrument [Line Items] | |
2023 | $ 22 |
2024 | 13 |
2025 | 10 |
2026 | 3 |
Total notes payable | $ 48 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Details) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Commitments and Contingencies Disclosure [Abstract] | ||
Estimated litigation liability | $ 0 | $ 0 |
Commitments and Contingencies_2
Commitments and Contingencies - Schedule of Concentration of Risk, by Risk Factor (Details) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Supplier A | Supplier Concentration Risk | Cost of Goods and Service, Product and Service Benchmark | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 17% | 21% | |
Supplier B | Supplier Concentration Risk | Cost of Goods and Service, Product and Service Benchmark | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 13% | 13% | |
Customer A | Customer Concentration Risk | Net Sales Revenue | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 30% | 30% | 35% |
Customer A | Customer Concentration Risk | Accounts Receivable | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 16% | 18% | |
Customer B | Customer Concentration Risk | Net Sales Revenue | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 24% | 23% | 19% |
Customer B | Customer Concentration Risk | Accounts Receivable | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 23% | 19% |
Derivative Instruments - Summar
Derivative Instruments - Summary of Notional Amount and Fair Value of All Outstanding Derivative Instruments (Details) - Not Designated as Hedging Instrument - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Receive USD/pay GBP | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | $ 1,104 | $ 125 |
Receive BRL/sell USD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 2,314 | |
Derivative liability, fair value | (2,389) | |
Receive USD/pay CAD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 188 | |
Derivative liability, fair value | (57) | |
Receive USD/pay EUR | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, fair value | (7) | |
Receive THB/sell USD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, fair value | (64) | (751) |
Receive MYR/sell USD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 1 | |
Derivative assets | Receive USD/pay GBP | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, notional amount | 23,702 | 22,323 |
Derivative assets | Receive BRL/sell USD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, notional amount | 46,301 | |
Derivative assets | Receive USD/pay CAD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, notional amount | 4,819 | |
Derivative assets | Receive MYR/sell USD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, notional amount | 392 | |
Derivative liabilities | Receive BRL/sell USD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, notional amount | 43,174 | |
Derivative liabilities | Receive USD/pay CAD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, notional amount | 4,731 | |
Derivative liabilities | Receive USD/pay EUR | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, notional amount | 604 | |
Derivative liabilities | Receive THB/sell USD | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, notional amount | $ 21,990 | $ 18,488 |
Derivative Instruments - Summ_2
Derivative Instruments - Summary of Realized and Unrealized Gains and Losses of the Derivative Instruments (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Derivatives, Fair Value [Line Items] | |||
Unrealized gain (loss) on derivative instruments | $ 6,606 | $ 2,093 | $ (4,718) |
Unrealized gain (loss) on derivative instruments | |||
Derivatives, Fair Value [Line Items] | |||
Unrealized gain (loss) on derivative instruments | 6,606 | 2,093 | (4,718) |
Foreign currency gain (loss) | |||
Derivatives, Fair Value [Line Items] | |||
Foreign currency gain (loss) | $ 2,682 | $ (5,679) | $ 6,765 |
Fair Value Measurements - Summa
Fair Value Measurements - Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities measured at fair value | $ 3,535 | $ (3,071) |
Fair Value, Inputs, Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities measured at fair value | 0 | 0 |
Forward Currency Swaps/Contracts | Fair Value, Inputs, Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities measured at fair value | 3,535 | (3,071) |
Contingent consideration liability | Fair Value, Inputs, Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities measured at fair value | $ 0 | $ 0 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Details) - USD ($) | 12 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||
Percentage of revenue growth rate of the product | 49% | |||
Number of calendar months for trailing the revenue growth rate of the product | 12 months | |||
Loss on extinguishment of debt | $ 0 | $ 0 | $ 16,400,000 | |
AMI Runa US LLC | ||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||
Fair value of contingent consideration | 0 | $ 0 | $ 15,700,000 | |
AMI Runa US LLC | Revenue Growth Achieved | Maximum | ||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||
Fair value of contingent consideration | $ 51,500,000 |
Shareholders' Equity - Addition
Shareholders' Equity - Additional Information (Details) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||
Jan. 31, 2021 USD ($) $ / shares shares | Dec. 31, 2020 shares | Dec. 31, 2019 grantee shares | Dec. 31, 2022 USD ($) shares | Mar. 31, 2021 shares | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) $ / shares shares | Dec. 31, 2020 USD ($) | Aug. 17, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Treasury stock (in shares) | shares | 6,206,200 | 6,206,200 | |||||||
Common shares reserved for future issuance (in shares) | shares | 2,898,930,000 | 2,898,930,000 | 3,434,312,000 | ||||||
Stock issued during period, share ratio for non-controlling interest (in shares) | shares | 5.485 | 5.485 | |||||||
Stock-based compensation expense | $ 6,134,000 | $ 3,103,000 | $ 1,517,000 | ||||||
Stock-based sales incentive | 1,250,000 | 277,000 | |||||||
Impact to additional paid-in capital related to stock-based compensation arrangements | $ 7,384,000 | $ 3,380,000 | 1,517,000 | ||||||
Plan modification, number of grantees affected | grantee | 53 | ||||||||
Service-based Stock Options | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Award vesting period | 10 years | ||||||||
Weighted average grant-date fair value (in dollars per share) | $ / shares | $ 6.98 | $ 5.62 | |||||||
Aggregate intrinsic value of options exercised | $ 2,026,000 | $ 66,000 | |||||||
Plan modification, shares modified (in shares) | shares | 1,877,785,000 | ||||||||
Weighted average expected dividend yield | 0% | 0% | |||||||
Unrecognized compensation cost | $ 4,425,000 | $ 4,425,000 | |||||||
Unrecognized compensation cost, period for recognition | 2 years 2 months 12 days | ||||||||
Exercisable - end of period (in shares) | shares | 2,129,042 | 2,129,042 | |||||||
Performance and Market-based Stock Options | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Percentage of vesting of award under share-based payment arrangement. | 50% | ||||||||
Plan modification, incremental cost | $ 0 | ||||||||
Weighted average expected dividend yield | 0% | ||||||||
Unrecognized compensation cost | $ 1,606,000 | $ 1,606,000 | $ 1,599,000 | ||||||
Unrecognized compensation cost, period for recognition | 4 years 2 months 19 days | ||||||||
Shares purchased for award (in shares) | shares | 579,670,000 | ||||||||
Exercisable - end of period (in shares) | shares | 0 | 0 | |||||||
Fair value assumptions, exercise price (in dollars per share) | $ / shares | $ 2.11 | ||||||||
Performance and Market-based Stock Options | IPO | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Shares purchased for award (in shares) | shares | 68,250,000 | ||||||||
Performance-based stock options | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Weighted average grant-date fair value (in dollars per share) | $ / shares | $ 4.38 | $ 4.56 | |||||||
Unrecognized compensation cost | $ 403,000 | ||||||||
Unrecognized compensation cost, period for recognition | 3 years 2 months 4 days | ||||||||
Shares purchased for award (in shares) | shares | 262,990,000 | ||||||||
Restricted Stock Units (RSUs) | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Unrecognized compensation cost | $ 5,035,000 | $ 5,035,000 | $ 3,261,000 | ||||||
Unrecognized compensation cost, period for recognition | 2 years 8 months 12 days | 2 years 1 month 6 days | |||||||
Grants in period, aggregate grant date fair value | $ 4,445,000 | $ 3,837,000 | |||||||
Restricted Stock | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Aggregate intrinsic value, nonvested | $ 3,000,000 | $ 3,000,000 | |||||||
Granted (in dollars per share) | $ / shares | $ 15 | ||||||||
Granted (in shares) | shares | 200,000 | ||||||||
Tranche One | Restricted Stock | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Percentage of vesting of award under share-based payment arrangement. | 50% | ||||||||
Tranche Two | Restricted Stock | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Percentage of vesting of award under share-based payment arrangement. | 50% | ||||||||
2014 Plan | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Percentage of outstanding stock maximum | 8% | ||||||||
Award vesting period | 10 years | ||||||||
2014 Plan | Tranche One | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Percentage of vesting of award under share-based payment arrangement. | 50% | ||||||||
Award requisite service period (in years) | 2 years | ||||||||
2014 Plan | Tranche Two | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Percentage of vesting of award under share-based payment arrangement. | 50% | ||||||||
Award requisite service period (in years) | 4 years | ||||||||
2021 Plan | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Percentage of outstanding stock maximum | 2% | ||||||||
Maximum | 2021 Plan | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common shares reserved for future issuance (in shares) | shares | 3,431,312 | 3,431,312 | |||||||
All Market Europe, Ltd. | Maximum | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Noncontrolling interest, ownership percentage by noncontrolling owners | 1.30% | ||||||||
All Market Europe, Ltd. | Minimum | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Noncontrolling interest, ownership percentage by noncontrolling owners | 0.71% | ||||||||
Common Stock | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock repurchased during period (in shares) | shares | 5,192,005 | ||||||||
Purchase price per share (in dollars per share) | $ / shares | $ 9.63 | ||||||||
Stock repurchased during period | $ 50,000,000 | ||||||||
Additional Paid-In Capital | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Impact to additional paid-in capital related to stock-based compensation arrangements | $ 7,384,000 | $ 3,380,000 | $ 1,517,000 |
Shareholders' Equity - Summary
Shareholders' Equity - Summary of Stock Option Activity (Details) $ / shares in Units, $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) $ / shares shares | |
Service-based Stock Options | |
Number of Stock Options | |
Outstanding - beginning balance (in shares) | 4,117,671 |
Granted (in shares) | 128,940 |
Exercise of stock options (in shares) | 370,940 |
Forfeited (in shares) | 161,697 |
Outstanding - ending balance (in shares) | 3,713,974 |
Exercisable - end of period (in shares) | 2,129,042 |
Weighted- Average Exercise Price | |
Outstanding - beginning balance (in dollars per share) | $ / shares | $ 10.34 |
Granted (in dollars per share) | $ / shares | 15.36 |
Exercised (in dollars per share) | $ / shares | 8.36 |
Forfeited (in dollars per share) | $ / shares | 11.27 |
Outstanding - ending balance (in dollars per share) | $ / shares | 11 |
Exercisable - end of period (in dollars per share) | $ / shares | $ 10.29 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | |
Weighted Average Remaining Contractual Term (in years) | 7 years |
Weighted Average Remaining Contractual Term (in years), Exercisable | 6 years 8 months 12 days |
Aggregate Intrinsic Value | $ | $ 10,062 |
Aggregate Intrinsic Value, Exercisable | $ | $ 7,522 |
Performance and Market-based Stock Options | |
Number of Stock Options | |
Outstanding - beginning balance (in shares) | 778,960 |
Granted (in shares) | 38,675 |
Exercise of stock options (in shares) | 0 |
Forfeited (in shares) | 9,100 |
Outstanding - ending balance (in shares) | 808,535 |
Exercisable - end of period (in shares) | 0 |
Weighted- Average Exercise Price | |
Outstanding - beginning balance (in dollars per share) | $ / shares | $ 10.33 |
Granted (in dollars per share) | $ / shares | 10.18 |
Exercised (in dollars per share) | $ / shares | 0 |
Forfeited (in dollars per share) | $ / shares | 10.18 |
Outstanding - ending balance (in dollars per share) | $ / shares | $ 10.32 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | |
Weighted Average Remaining Contractual Term (in years) | 6 years 10 months 24 days |
Aggregate Intrinsic Value | $ | $ 2,658 |
Shareholders' Equity - Summar_2
Shareholders' Equity - Summary of Weighted Average Assumptions Used in The Black-Scholes Option-pricing Model (Details) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Service-based Stock Options | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted average expected term | 7 years | 6 years 3 months 18 days |
Weighted average expected volatility | 39% | 39% |
Weighted average risk-free interest rate | 2.86% | 1.19% |
Weighted average expected dividend yield | 0% | 0% |
Performance and Market-based Stock Options | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted average expected term | 2 years 5 months 8 days | |
Weighted average expected volatility | 40% | |
Weighted average risk-free interest rate | 0.16% | |
Weighted average expected dividend yield | 0% |
Stockholders' Equity - Summary
Stockholders' Equity - Summary of Restricted Stock and Restricted Stock Unit Activity (Details) - Restricted Stock and Restricted Stock Units (RSUs) | 12 Months Ended |
Dec. 31, 2022 $ / shares shares | |
Number of Restricted Stock or RSU Awards | |
Non-vested - beginning of period (in shares) | shares | 454,881 |
Granted (in shares) | shares | 342,637 |
Vested (in shares) | shares | 89,728 |
Forfeited/Cancelled (in shares) | shares | 41,613 |
Non-vested - end of period (in shares) | shares | 666,177 |
Weighted Average Grant Date Fair Value | |
Non-vested - beginning of period (in dollars per share) | $ / shares | $ 15 |
Granted (in dollars per share) | $ / shares | 12.97 |
Vested (in dollars per share) | $ / shares | 15 |
Forfeited/Cancelled (in dollars per share) | $ / shares | 13.12 |
Non-vested - end of period (in dollars per share) | $ / shares | $ 14.08 |
Income Taxes - Schedule of Inco
Income Taxes - Schedule of Income Before Income Tax, Domestic and Foreign (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
Domestic | $ 5,634 | $ 15,085 | $ 33,412 |
Foreign | 5,207 | 9,144 | 10,188 |
Income before income taxes | $ 10,841 | $ 24,229 | $ 43,600 |
Income Taxes - Schedule of Comp
Income Taxes - Schedule of Components of Income Tax Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Current | |||
Federal | $ 3,654 | $ 3,343 | $ 1,871 |
State and local | 1,477 | 1,076 | 886 |
Foreign | 965 | 2,435 | 1,874 |
Current income tax expense | 6,096 | 6,854 | 4,631 |
Deferred | |||
Federal | (2,940) | (304) | 4,884 |
State and local | (839) | (29) | 1,403 |
Foreign | 710 | (1,284) | (5) |
Deferred income tax expense | (3,069) | (1,617) | 6,282 |
Total | $ 3,027 | $ 5,237 | $ 10,913 |
Income Taxes - Schedule of Effe
Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
Income tax benefit using U.S. federal statutory rate | 21% | 21% | 21% |
State and local taxes. net of U.S. federal income tax benefit | 4.70% | 3.60% | 4.70% |
Global intangible low-taxed income | 0% | 1.80% | 2.70% |
Stock compensation | (3.90%) | 0% | 0% |
Officer's compensation limitation | 4.40% | 0% | 0% |
Tax attribute expiration | 0% | 0% | 1.50% |
Permanent differences | 0.30% | 0.40% | (0.10%) |
Foreign rate differential | (2.90%) | (1.80%) | (0.40%) |
Foreign derived intangible income | (3.60%) | (1.90%) | (0.80%) |
Valuation allowance | 5.40% | (3.20%) | (1.20%) |
Return to provision | 0% | (0.10%) | 0.30% |
Tax credits | (0.60%) | (1.80%) | (2.70%) |
IPO costs | 0% | 2.10% | 0% |
Other | 3.10% | 1.50% | 0% |
Provision for income taxes | 27.90% | 21.60% | 25% |
Income Taxes - Schedule of Defe
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Deferred Tax Assets: | ||
Inventory reserves | $ 878 | $ 562 |
Reserves and accruals | 1,330 | 868 |
Stock based compensation | 3,728 | 2,632 |
Net operating loss carryforwards | 4,834 | 5,454 |
Charitable contributions carryforward | 0 | 356 |
Lease liability | 673 | 0 |
Subtotal | 11,443 | 9,872 |
Valuation allowance | (4,586) | (4,267) |
Total deferred tax assets | 6,857 | 5,605 |
Deferred Tax Liabilities: | ||
Prepaid insurance | (397) | (615) |
Intangibles | (1,464) | (3,453) |
Right-of-use assets | (646) | 0 |
Fixed assets | (84) | (183) |
Other—Net | (10) | (89) |
Total deferred tax liabilities | (2,601) | (4,340) |
Net deferred tax assets | $ 4,256 | $ 1,265 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Operating Loss Carryforwards [Line Items] | ||
Valuation allowance | $ 4,586,000 | $ 4,267,000 |
Beginning balance as of January 1, 2022 | 0 | |
Unrecognized tax benefits, income tax penalties and interest expense | $ 50,000 | 50,000 |
Minimum | ||
Operating Loss Carryforwards [Line Items] | ||
Operating loss carryforward, expiration period | 10 years | |
Foreign | ||
Operating Loss Carryforwards [Line Items] | ||
Valuation allowance | $ 4,586,000 | 4,267,000 |
Operating loss carryforwards | 22,987,000 | 24,920,000 |
State | ||
Operating Loss Carryforwards [Line Items] | ||
Operating loss carryforwards | $ 0 | $ 0 |
Income Taxes - Schedule of Unre
Income Taxes - Schedule of Unrecognized Tax Benefits Roll Forward (Details) | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |
Beginning balance as of January 1, 2022 | $ 0 |
Additions based on tax positions related to prior years | 144,000 |
Additions based on tax positions related to current year | 0 |
Ending balance as of December 31, 2022 | $ 144,000 |
Earnings Per Share - Summary of
Earnings Per Share - Summary of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Numerator: | |||
Net income attributable to The Vita Coco Company, Inc. | $ 7,814 | $ 19,015 | $ 32,660 |
Denominator: | |||
Weighted-average number of common shares used in earnings per share - basic (in shares) | 55,732,619 | 53,689,910 | 58,501,170 |
Effect of conversion of stock options and RSUs (in shares) | 391,042 | 496,211 | 109,655 |
Weighted-average number of common shares used in earnings per share - diluted (in shares) | 56,123,661 | 54,186,121 | 58,610,825 |
Earnings per share - basic (in dollars per share) | $ 0.14 | $ 0.35 | $ 0.56 |
Earnings per share - diluted (in dollars per share) | $ 0.14 | $ 0.35 | $ 0.56 |
Earnings Per Share - Additional
Earnings Per Share - Additional Information (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2022 | |
Class of Warrant or Right [Line Items] | ||
Annual internal rate of return provided by proceeds from a liquidity event (less than) | 30% | |
Vested Service Warrants | ||
Class of Warrant or Right [Line Items] | ||
Exercise price of warrants (in dollars per share) | $ 0.000022 |
Earnings Per Share - Summary _2
Earnings Per Share - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Payment Arrangement, Option | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Options to purchase common stock (in shares) | 1,880,904 | 1,288,350 | 3,719,625 |
Employee Benefit Plan (Details)
Employee Benefit Plan (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Retirement Benefits [Abstract] | |||
Employer matching contribution, percent of employees' earnings | 3% | ||
Employers matching contribution, vesting period | 2 years | ||
Matching contributions | $ 592 | $ 475 | $ 372 |
Segment Reporting - Additional
Segment Reporting - Additional Information (Details) | 12 Months Ended |
Dec. 31, 2022 segment | |
Segment Reporting [Abstract] | |
Number of operating segments | 2 |
Number of reportable segments | 2 |
Segment Reporting - Schedule of
Segment Reporting - Schedule of Segment Reporting Information by Segment (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Segment Reporting Information [Line Items] | |||
Net sales | $ 427,787 | $ 379,513 | $ 310,644 |
Gross profit | 103,361 | 113,148 | 104,858 |
Total assets | 197,757 | 197,484 | |
Operating Segments | Americas | |||
Segment Reporting Information [Line Items] | |||
Net sales | 373,622 | 323,891 | 262,899 |
Gross profit | 95,492 | 101,864 | 90,256 |
Total assets | 156,588 | 141,973 | |
Operating Segments | International | |||
Segment Reporting Information [Line Items] | |||
Net sales | 54,165 | 55,622 | 47,745 |
Gross profit | 7,869 | 11,284 | $ 14,602 |
Total assets | $ 41,169 | $ 55,511 |
Segment Reporting - Reconciliat
Segment Reporting - Reconciliation of Gross Profit to Income Loss Before Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Segment Reporting [Abstract] | |||
Gross profit | $ 103,361 | $ 113,148 | $ 104,858 |
Selling, general and administrative expenses | 100,306 | 88,559 | 74,401 |
Change in fair value of contingent consideration | 0 | 0 | (16,400) |
Income from operations | 3,055 | 24,589 | 46,857 |
Unrealized (gain)/loss on derivative instruments | (6,606) | (2,093) | 4,718 |
Foreign currency (gain) loss | (1,387) | 2,088 | (1,848) |
Loss on extinguishment of debt | 0 | 132 | 0 |
Interest income | (51) | (127) | (404) |
Interest expense | 258 | 360 | 791 |
Income before income taxes | $ 10,841 | $ 24,229 | $ 43,600 |
Segment Reporting - Net Revenue
Segment Reporting - Net Revenues by Country (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | $ 427,787 | $ 379,513 | $ 310,644 |
United States | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | 352,731 | 323,891 | 262,899 |
All other countries | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Net sales | $ 75,056 | $ 55,622 | $ 47,745 |
Segment Reporting - Property an
Segment Reporting - Property and Equipment, Net By Country (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property and equipment, net | $ 2,579 | $ 2,473 |
United States | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property and equipment, net | 683 | 890 |
Ecuador | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property and equipment, net | 503 | 870 |
Singapore | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property and equipment, net | 1,288 | 536 |
All other countries | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property and equipment, net | $ 105 | $ 177 |
Related-Party Transactions (Det
Related-Party Transactions (Details) $ in Thousands | 12 Months Ended | |||||
May 18, 2020 | Sep. 18, 2019 USD ($) shares | Dec. 31, 2022 USD ($) director | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | May 24, 2022 director | |
Related Party Transaction [Line Items] | ||||||
Number of members of the Board of Directors appointed as nominees | director | 1 | 2 | ||||
Management Fee Payments | Affiliated Entity | ||||||
Related Party Transaction [Line Items] | ||||||
Related party transaction, amounts of transaction | $ 281 | $ 227 | ||||
Loan to Employee | Affiliated Entity | Promissory Note | ||||||
Related Party Transaction [Line Items] | ||||||
Debt instrument, term | 5 years | |||||
Debt instrument, face amount | $ 17,700 | |||||
Related party transaction, rate | 0.58% | 1.78% | ||||
Debt instrument, funds disbursed | $ 0 | |||||
Loan to Employee | Affiliated Entity | Promissory Note | Common Stock | ||||||
Related Party Transaction [Line Items] | ||||||
Share-based compensation arrangement by share-based payment award, shares issued (in shares) | shares | 1,739,010,000 | |||||
Distribution Agreement With Shareholder | Affiliated Entity | ||||||
Related Party Transaction [Line Items] | ||||||
Revenue from related parties | 6,375 | 6,247 | $ 5,294 | |||
Accounts receivable, related parties, current | 753 | 600 | ||||
Accounts payable, related parties, current | 38 | 71 | ||||
Service Agreement Related To Distribution Agreement With Shareholder | Affiliated Entity | ||||||
Related Party Transaction [Line Items] | ||||||
Related party transaction, selling, general and administrative expenses from transactions with related party | $ 234 | $ 215 | $ 132 | |||
Minimum | Management Fee Payments | Affiliated Entity | ||||||
Related Party Transaction [Line Items] | ||||||
Related party transaction, stockholder ownership percentage | 5% |
Assets Held For Sale - Narrativ
Assets Held For Sale - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Discontinued Operations and Disposal Groups [Abstract] | |||
Impairment loss on assets held for sale | $ 619 | $ 0 | $ 90 |
Assets Held For Sale - Schedule
Assets Held For Sale - Schedule of Assets Held For Sale (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Discontinued Operations and Disposal Groups [Abstract] | ||
Asset held for sale | $ 503 | $ 0 |
Leases - Components of Lease Co
Leases - Components of Lease Cost (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Leases [Abstract] | |
Operating lease cost | $ 1,124 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information for Operating Leases (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2021 |
Noncurrent assets: | |||
Operating lease right-of-use assets | $ 2,679 | $ 1,866 | $ 0 |
Current liabilities: | |||
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Accrued expenses | ||
Current portion of operating lease liabilities | $ 734 | $ 0 | |
Noncurrent liabilities: | |||
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other long-term liabilities | ||
Non-current portion of operating lease liabilities | $ 2,052 |
Leases - Summary of the Weighte
Leases - Summary of the Weighted Average Remaining Lease Term and Weighted Average Discount Rate (Details) | Dec. 31, 2022 |
Leases [Abstract] | |
Weighted-average remaining lease terms | 2 years 4 months 24 days |
Weighted average discount rate | 1.50% |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flows for Leases (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Leases [Abstract] | |
Cash paid for amounts included in the measurement of operating lease liabilities | $ 1,197 |
Leases - Schedule of Operating
Leases - Schedule of Operating Lease Liability Maturity (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 |
Leases [Abstract] | ||
2023 | $ 1,218 | |
2024 | 1,218 | |
2025 | 437 | |
2026 | 0 | |
Thereafter | 0 | |
Total lease payments | 2,873 | |
Less: imputed interest | (87) | |
Total lease liabilities | $ 2,786 | $ 2,097 |
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] | Accrued expenses, Other long-term liabilities | Accrued expenses, Other long-term liabilities |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) $ in Thousands | Dec. 31, 2021 USD ($) |
Leases [Abstract] | |
2022 | $ 1,085 |
2023 | 226 |
2024 | 154 |
2025 | 51 |
2026 | 0 |
Thereafter | 0 |
Operating leases, future minimum payments due | $ 1,516 |